Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

	Results for 'Pharmaceutical Sales Management'

Title	Publication Date	Price	Relevance
Pharmaceutical Sales Management 2008	August 2007	£5080	100 %
Reinventing Pharmaceutical Sales Forces	May 2009	£5080	62 %
Pharmaceutical Sales Force Effectiveness Metrics Are You Measuring the Wrong Things?	November 2007	£497	61 %
The High Performing Pharmaceutical District Sales Manager Current Trends & Future Directions	July 2008	£5565	60 %
Winning Product Launch Strategies Maximizing sales from new pharmaceutical products	April 2007	£1495	59.5 %
U.S. Sales Communications Excellence Resources, Structure and Processes to Optimize Pharmaceutical Sales Communications	April 2008	£955	58.1 %
Pharmaceutical Goods Retailing in Australia IBISWorld Industry Report	August 2007	£460	50 %
Accelerate M&A Success Making Integration Work	December 2007	£4620	41 %
New Drug Futures: Alimentary/Metabolic Chapter	May 2006	£695	37 %
Pharmaceutical Sales Training Groups Building Better Sales Forces	October 2006	£2175	36 %
Managing Sales Training to Accelerate Speed to Productivity	December 2004	£1530	35.5 %
Dale & Applebe's Pharmacy Law & Ethics 8th Edition	September 2005	£34.95	35 %
Streamlining Information in the Pharmaceutical Industry with Product Lifecycle Management Solutions (Executive Presentation)	August 2007	£660	35 %
Managing Process Complexity in the Pharmaceutical Industry with PLM (Strategy Focus)	August 2007	£660	34.5 %
World Pharmaceutical Drug Market Sector Snapshot	September 2006	£330	34.5 %
New Drug Futures: Respiratory Chapter	May 2006	£695	33 %
EGIS Pharmaceuticals Plc - Strategic Analysis Review	March 2009	£83	31.5 %
SanofiAventis SWOT Analysis	November 2008	£44	31.5 %
Ono Pharmaceutical Co., Ltd. - SWOT Analysis	November 2008	£44	31.5 %
Pharmaceutical Co-Promotion Management	March 2006	£2905	31 %
IMS Health - SWOT Analysis	December 2008	£44	30.5 %
Virtual Pharma The Radical Route To Success	September 2008	£795	30.5 %
Healthcare Stakeholders in Latin America Secrets of Engagement	December 2009	£235	30.1 %
Sanofi-Aventis - SWOT Analysis	November 2008	£44	30 %
Bringing Drugs to Market The role of CRM in improving sales & marketing (Executive Presentation)	August 2007	£660	30 %
Pfizer PharmaVitae Profile	January 2007	£1980	30 %
Introduction to the Pharmaceutical Regulatory Process	November 2004	£94	29.5 %
Dr Reddy's Laboratories Generics Company Intelligence Report	June 2008	£195	29 %
Dr Reddy's Laboratories Generics Company Intelligence Report	June 2008	£195	29 %
King Pharmaceuticals: PharmaVitae Profile	January 2007	£1980	28.5 %
China Biopharmaceutical Industry Report, 2006-2007	March 2007	£195	28.5 %
Chinese Pharmaceutical Market Overview Regulatory reform and the evolving healthcare market provide opportunities in china	November 2007	£1980	28.5 %
Careers in the Pharmaceutical Industry Second Edition	March 2003	£30	28.35 %
Salix Pharmaceuticals Ltd Premium Company Profile	December 2007	£175	28 %
Boehringer Ingelheim Pipeline ,Products ,Performance ,Potential	November 2008	£595	28 %
Gilead PharmaVitae Profile	January 2007	£1980	28 %
New Drug Futures: Central Nervous System Chapter	May 2006	£695	27.5 %
Global Pharmaceutical Market Dynamics and Trends through 2016	September 2009	£990	27.5 %
Sales Force Effectiveness Benchmarking the Resources and Structure Required to Service the U.S. Hospital Marketplace	June 2006	£2280	27.5 %
The Rise of Mid-Sized Pharma What makes mid-sized companies successful – and what big Pharma can learn from them?	May 2008	£795	27.5 %
World Pharmaceutical Market (2007)	November 2006	£490	27.3 %
Stakeholder Opinions Gynecological Cancers Niche opportunities in advanced disease	November 2007	£1980	27 %
Opportunities and Challenges for Generic Drugs in the UK 2007	June 2007	£795	27 %
China Medical Sales Channel Report, 2006-2007	March 2007	£595	26.95 %
Online Pharmaceutical Industry, 2006-2011, The	July 2006	£1499	26.5 %
India Pharmaceutical Regulatory Report 2009	January 2009	£1020	26.5 %
Chiron: PharmaVitae Profile PharmaVitae Profile	March 2007	£1980	26.5 %
Genentech: PharmaVitae Profile Pharmavitae Profile	October 2007	£1980	26.5 %
The Chinese Pharmaceutical Directory 2008 How to keep up-to-date with China's Pharmaceutical businesses and discover hundreds of new business leads	November 2007	£225	26 %
The World Diabetes Market, 2007-2025 An Analysis of Diabetes Drug and Insulin Market	March 2009	£235	26 %
Par Pharmaceutical Companies, Inc. SWOT Analysis	October 2008	£44	26 %
New Drug Futures: Anti-Infective Chapter	May 2006	£695	25.5 %
UCB Schwarz: PharmaVitae Profile	February 2007	£1980	25.5 %
Amgen: PharmaVitae Profile	February 2007	£1980	25.5 %
New Drug Futures: Cardiovascular Chapter	May 2006	£695	25.5 %
Customer Loyalty and Satisfaction Creating a Branded Customer Experience	August 2006	£3965	25.5 %
Teva Pharmaceutical Industries - SWOT Analysis	October 2008	£44	25.5 %
New Drug Futures: Vaccines Chapter	May 2006	£695	25 %
Stada IMS Company Profile	November 2007	£249	25 %
Nycomed International Management GmbH - SWOT Analysis	June 2008	£44	25 %
Forest IMS Company Profile	November 2007	£249	25 %
Vernalis IMS Company Profile	November 2007	£249	25 %
2007 Trends to Watch: Pharmaceutical Technology	March 2007	£625	24.85 %
Tanabe Seiyaku Co., Ltd. - SWOT Analysis	May 2007	£42	24.5 %
Pharmaceutical Market Segmentation Spending, Strategy and Implementation	June 2006	£2905	24.5 %
Noven Pharmaceuticals Inc - SWOT Analysis	December 2008	£44	24.5 %
EvaluatePharma® Yearbook Company Performance Tables	August 2008	£1450	24.5 %
Commercial Insight: Osteoporosis Risk management and reformulation offer best defense against generic onslaught	June 2007	£5020	24.5 %
Johnson & Johnson Performance, Capabilities, Goals and Strategies in The Worldwide Pharmaceutical Market	September 2009	£1255	24.5 %
Leading Pharmaceutical Companies Comparative Analysis	September 2009	£295	24.5 %
BioMarin Pharmaceutical Inc - SWOT Analysis	March 2009	£44	24.5 %
Premium Company Profile Savient Pharmaceuticals	October 2007	£175	24.5 %
Guide to Pharma Pricing & Reimbursement Systems Western Europe	November 2005	£970	24.5 %
Lotus Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	24.5 %
Product Lifecycle Management, 2006	May 2006	£1499	24.5 %
Taisho Pharmaceutical Co Ltd OTC Profile	May 2005	£195	24.15 %
China Pharmaceutical Industry Report (Merger & Reorganization), 2006	August 2006	£1520	24.15 %
Developing Managed Care Pull-Through Excellence	October 2009	£3435	24 %
Company Study of Guangxi Wuzhou Zhongheng Group Co., Ltd., 2007	August 2007	£230	24 %
Business and Marketing Strategy for China's Pharmaceutical Market Webcast CD	October 2007	£265	24 %
China Pharmaceutical Industry: Analysis and Market Trends	January 2009	£330	24 %
2007 Worldwide Pharmaceutical Preparation Manufacturing Industry Report	January 2007	£130	24 %
Premium Company Profile: Endo Pharmaceuticals	November 2007	£175	24 %
Trends and Future Directions for the High Performing District Sales Manager A Comparative View from 2007 and 2009	February 2010	£4245	24 %
Rewarding & Recognizing Top-Performing Sales People	March 2008	£2290	23.5 %
Lifecycle Management Strategies Maximizing ROI through indication expansion, reformulation and Rx-to-OTC switching	January 2006	£1495	23.5 %
Novartis Pipeline ,Products ,Performance ,Potential	November 2009	£595	23.5 %
Ono Pharmaceutical Co., Ltd. SWOT Analysis	November 2008	£44	23.5 %
Takeda: Pipeline, Products,Performance,Potential	November 2009	£595	23.5 %
Mexico Pharmaceuticals 2005	October 2005	£150	23 %
Urinary Incontinence Markets Sector Snapshot	January 2006	£330	23 %
Europe IT Spending on Business Intelligence to 2012 Pharmaceutical Technology	April 2007	£460	23 %
Chinese Pharmaceutical Industry - Access China	January 2006	£230	23 %
Takeda Pharmaceutical Company Limited - SWOT Analysis	January 2009	£44	23 %
Daiichi Sankyo Pipeline, Products, Performance, Potential	October 2008	£595	23 %
Chugai Pipeline Products Performance Potential	October 2008	£595	23 %
Slovakia Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	22.5 %
European Pharmaceutical Directory 2009	February 2009	£230	22.5 %
CompanyStudyofJiangsuHengruiMedicineCo Ltd.,2007	June 2007	£230	22.5 %
2007 U.S. Pharmaceutical Preparation Mfg. Industry Report	October 2006	£98	22.5 %
Astellas Pipeline Products Performance Potential	June 2008	£595	22.5 %
Indian Pharmaceutical Market, 2006-2011	June 2006	£1499	22.5 %
Premium Company Profile - Amylin Pharmaceuticals	October 2007	£175	22.5 %
Johnson & Johnson Medical Device Company Intelligence Report	August 2009	£695	22.5 %
Best Practices in Global Pharmaceutical Launches	January 2007	£4625	22.5 %
Stakeholder Insight Pricing and Reimbursement in Oncology Do payers believe oncology drugs offer good value	November 2007	£1980	22.5 %
Novartis PharmaVitae Profile	January 2007	£1980	22.5 %
Snapshots Italy Pharmaceuticals 2005	December 2005	£150	22.5 %
Snapshots Sweden Pharmaceuticals 2005	December 2005	£150	22.5 %
Vivus, Inc. - SWOT Analysis	September 2008	£44	22.5 %
Obesity Drug Markets in the US and EU Analysis of product pipelines and the competitive environment	July 2008	£1995	22.4 %
Kv Pharmaceutical Company Premium Company Profile	April 2008	£175	22.4 %
Pain Management Global Trends	November 2009	£1980	22.05 %
Taisho Pharmaceutical Co Ltd - OTC Healthcare - World	December 2008	£245	22.05 %
Quality for Biologics Critical quality attributes, process and change control, product variation, characterisation, and regulatory concerns	December 2008	£1495	22 %
AmerisourceBergen Corporation - Financial and Strategic Analysis Review	June 2009	£83	22 %
Stakeholder Insight Atherosclerosis HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities for future treatment	October 2007	£1980	22 %
Astellas: Pipeline, Products, Performance, Potential	January 2010	£595	22 %
Smith & Nephew Medical Device Company Intelligence Report	April 2007	£395	22 %
Little Black Book of Pharma Marketing; The	April 2002	£100	22 %
Nycomed International Management GmbH - Strategic Analysis Review	July 2009	£83	22 %
Takeda Pharmaceutical Co. Ltd: PharmaVitae Model	January 2009	£1990	22 %
UCB S.A.: PharmaVitae Model	January 2009	£1990	22 %
Generics will play an increasingly important role in the pharma industry	October 2006	£590	22 %
Premium Company Profile: BioMarin Pharmaceutical Inc.	November 2007	£175	21.7 %
Forest Laboratories Pipeline Products Performance Potential	October 2007	£595	21.7 %
Otsuka Pharmaceutical Co Ltd - OTC Healthcare - World	November 2008	£245	21.7 %
AstraZeneca plc: PharmaVitae Model	January 2009	£1990	21.5 %
Chugai Pharmaceutical Co. Ltd: PharmaVitae Model	January 2009	£1990	21.5 %
Cephalon Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
SkyePharma PLC - Financial and Strategic Analysis Review	July 2009	£83	21.5 %
GlaxoSmithKline: PharmaVitae Profile PharmaVitae Profile	January 2007	£1980	21.5 %
Biogen Idec: PharmaVitae Profile PharmaVitae Profile	March 2007	£1980	21.5 %
Celgene Corporation: PharmaVitae Model	January 2009	£1990	21.5 %
Best Practices in Designing Effective Brand Teams Brand Governance and Brand Team Management	December 2007	£2145	21.5 %
Pipeline Insight: Non-Small Cell Lung Cancer Pipeline set to offer only modest improvements	April 2008	£3965	21.5 %
Actelion Ltd: PharmaVitae Model	January 2009	£1990	21.5 %
Abbott Laboratories: PharmaVitae Model	January 2009	£1990	21.5 %
Alcon Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
Allergan Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
Eisai Co. Ltd: PharmaVitae Model	January 2009	£1990	21.5 %
Astellas Pharma Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
Amgen Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
Genzyme: PharmaVitae Profile	November 2006	£3000	21.5 %
Eli Lilly & Co.: PharmaVitae Model	January 2009	£1990	21.5 %
Pfizer Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
Sandoz International GmbH: PharmaVitae Model	January 2009	£1990	21.5 %
Snapshots Germany Pharmaceuticals 2007	June 2007	£150	21.5 %
Nycomed A/S: PharmaVitae Model	January 2009	£1990	21.5 %
Wyeth: PharmaVitae Model	January 2009	£1990	21.5 %
H. Lundbeck A/S: PharmaVitae Model	January 2009	£1990	21.5 %
Sepracor Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
Teva Pharmaceutical Industries Ltd: PharmaVitae Model	January 2009	£1990	21.5 %
Watson Pharmaceuticals Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
Solvay S.A.: PharmaVitae Model	January 2009	£1990	21.5 %
Shire plc: PharmaVitae Model	January 2009	£1990	21.5 %
Shionogi & Co. Ltd: PharmaVitae Model	January 2009	£1990	21.5 %
GlaxoSmithKline plc: PharmaVitae Model	January 2009	£1990	21.5 %
Snapshots Germany Pharmaceuticals 2007	June 2007	£150	21.5 %
Novartis AG: PharmaVitae Model	January 2009	£1990	21.5 %
Genentech Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
Merck & Co. Inc: PharmaVitae Model	January 2009	£1990	21.5 %
Les Laboratoires Servier: PharmaVitae Model	January 2009	£1990	21.5 %
Forest Laboratories Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
Merck KGaA: PharmaVitae Model	January 2009	£1990	21.5 %
Gilead Sciences Inc.: PharmaVitae Model	January 2009	£1990	21.5 %
Snapshots Germany Pharmaceuticals 2007	June 2007	£150	21.5 %
F. Hoffmann-La Roche: PharmaVitae Model	January 2009	£1990	21.5 %
Genzyme Corporation: PharmaVitae Model	January 2009	£1990	21.5 %
Menarini: PharmaVitae Model	January 2009	£1990	21.5 %
Optimizing Sales Force Effectiveness Using eHealth Applications to Improve the Quality of Physician Interactions	January 2006	£2510	21.35 %
Chinese Markets for Pharmaceutical Packaging	June 2009	£2440	21.35 %
Foundation in Pharmacy Practice	June 2008	£24.95	21.35 %
New Drug Futures: Musculoskeletal Chapter	May 2006	£695	21.35 %
Commercial Insight: Cytotoxic Therapy Cancer Brands Looming Patent Expiries Limit Market Growth	July 2008	£5020	21 %
Medical Device Product Management Benchmarking Development, Marketing and Promotion	May 2006	£2905	21 %
Boehringer Ingelhgeim GmbH: PharmaVitae Model	January 2009	£1990	21 %
Biogen Idec Inc.: PharmaVitae Model	January 2009	£1990	21 %
Bayer Schering Pharma AG: PharmaVitae Model	January 2009	£1990	21 %
Schering-Plough Corporation: PharmaVitae Model	January 2009	£1990	21 %
Mitsubishi Tanabe Pharma Corporation: PharmaVitae Model	January 2009	£1990	21 %
Biosimilars Benchmarking the key players PharmaVitae Profile	November 2007	£1980	21 %
International Directory of Pharmaceutical Companies 2009	January 2009	£525	21 %
Commercial and Pipeline Perspectives Obesity Lack of Reimbursement Limits Market Potential	November 2007	£1320	21 %
Pierre Fabre: PharmaVitae Profile	November 2006	£3000	21 %
Novo Nordisk A/S: PharmaVitae Model	January 2009	£1990	21 %
Bristol-Myers Squibb Co.: PharmaVitae Model	January 2009	£1990	21 %
Sanofi-Aventis: PharmaVitae Model	January 2009	£1990	21 %
Snapshots China OTC Pharmaceuticals 2009	May 2009	£300	21 %
Eisai: PharmaVitae Profile	November 2006	£3000	21 %
Osteoporosis Market Forecast	July 2009	£10040	21 %
Johnson & Johnson: PharmaVitae Model	January 2009	£1990	21 %
Lung Cancer Therapeutics Market Outlook and Pipeline Analysis	November 2009	£985	21 %
Dainippon Sumitomo Pharma Co. Ltd: PharmaVitae Model	January 2009	£1990	21 %
Ensuring Profitable Patient Adherence Programs Using Analytics and Metrics to Improve the Bottom Line	March 2008	£497	21 %
New Drug Futures: Cancer Chapter	May 2006	£695	21 %
PharmaVitae Generics - Teva	July 2007	£1325	21 %
Iran Pharmaceuticals and Healthcare Report Q1 2010	November 2009	£250	21 %
Uzbekistan Pharmaceuticals and Healthcare Report Q1 2010	November 2009	£250	21 %
Pipeline Insight Migraine Innovation essential as weak late-stage pipeline fails to hold off the impact of triptan patent expiries	November 2007	£1980	21 %
Daiichi Sankyo Co., Ltd: PharmaVitae Model	January 2009	£1990	21 %
Thailand Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	21 %
Understanding the Global Pharmaceutical Market	November 2008	£395	20.65 %
The Scandinavian Pharmaceutical Market Outlook to 2013 Policy environment, market structure, pipeline analysis, growth opportunities	March 2009	£2025	20.65 %
Cephalon Inc. Pharmavitae Profile	December 2007	£1980	20.65 %
Who's Developing What in Drug Delivery?	November 2009	£595	20.5 %
Nipro Medical Device Company Intelligence Report	November 2008	£395	20.5 %
Johnson & Johnson Prospects to 2010	June 2007	£595	20.5 %
Noven Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	20.5 %
Latest Chinese Regulations for Imported Drug Registration: A Comprehensive Guidebook for Foreign Pharmaceutical Companies China Pharmaceutical Guidebook Series (1) (3rd edition)	October 2009	£495	20.5 %
Merck & Co: PharmaVitae Profile	November 2006	£1980	20.5 %
Lundbeck: PharmaVitae Profile	November 2006	£3000	20.5 %
Immunogenicity to Biologics Implications Of Reactions Against Biotech Drugs	November 2007	£1450	20 %
Snapshots China Pharmaceuticals 2007	March 2007	£150	20 %
Singaporean Pharmaceuticals and Life Sciences IT Market	December 2008	£5285	20 %
Pipeline Insight Therapeutic Cancer Vaccines A turbulent path from bench to bedside	October 2007	£1980	20 %
Managed Markets Account Management Assessing the Performance of Account Executives	October 2009	£2780	20 %
PharmaVitae: Company Comparator Tool	January 2009	£15890	20 %
Csl Limited Premium Company Profile	April 2008	£175	20 %
Pre-Launch Planning Priming Your Pharmaceutical Brand for Profit and Success	November 2008	£997	20 %
Commercial Insight: Targeted Therapy Cancer Brands High Growth Market Will See Eight New Blockbusters by 2017	July 2008	£5020	20 %
Medicis Pharmaceutical Corporation Premium Company Profile	December 2007	£175	19.95 %
The Pain Market Outlook to 2011	June 2006	£1495	19.95 %
Biogen Idec Inc. Pharmavitae Profile	December 2007	£1980	19.95 %
Taking CRM to the Next Level Web-assisted relationship- and community-building for the pharmaceutical industry	December 2006	£1325	19.6 %
Big Pharma's Key Lifecycle Management Strategies Maximizing The Market Potential	February 2010	£2310	19.6 %
Forest Laboratories Inc. Pharmavitae Profile	December 2007	£1990	19.6 %
The OTC market in Poland	June 2006	£1390	19.6 %
2007 Worldwide Pharmaceutical Preparation Mfg. Industry Report	January 2007	£130	19.5 %
Contract Pharmaceutical Manufacturing, Research, and Packaging	October 2009	£3205	19.5 %
Meiji Seika Kaisha, Ltd. - Financial and Strategic Analysis Review	April 2009	£83	19.5 %
Snapshots China Pharmaceuticals 2009	May 2009	£300	19.5 %
Strategic Alliances in World Pharma and Biotech Markets	November 2008	£395	19.5 %
China Pharmaceutical Industry Report 2006-2007	July 2007	£195	19.5 %
World Vaccines Market 2008-2013 Future Forecast, Critical Trends and Developments	April 2009	£335	19.5 %
Stakeholder Insight Alzheimer's Disease PharmaVitae Profile	October 2007	£1980	19.5 %
Bayer Schering Pharma AG - Financial and Strategic Analysis Review	April 2009	£83	19.5 %
Pharmaceutical New Product Commercialization: Preparing for Market Success	May 2008	£3540	19.5 %
The Return of the Rx to OTC Switch Market Analysis and Product Management Strategies	April 2008	£1320	19.5 %
King Pharmaceuticals Inc.: PharmaVitae Model	January 2009	£1990	19.5 %
Eli Lilly: Pipeline, Products,Performance,Potential	January 2010	£595	19.5 %
Actavis Group hf. - Strategic Analysis Review	March 2009	£83	19.5 %
Pharma Sales Forces Change in the Face of Adversity	October 2009	£235	19.25 %
Mergers, acquisitions and licensing to continue drive industry growth	October 2006	£590	19.25 %
Scrip's Pharmaceutical Company League Tables 2007	January 2007	£1870	19.25 %
Pharmaceutical Patient Adherehence and Disease Management Development, Management and Improvement	October 2006	£2905	19.25 %
ScientiaVision Competitor Close-up: Merck & Company, Inc.	December 2008	£525	19 %
Ono: Pipeline Products Performance Potential	November 2008	£595	19 %
China Hypertension Drug Market Report The Chinese Hospital Cancer Drug Utilization	February 2009	£5285	19 %
Procter & Gamble Performance, Products, Pipeline and Potential	November 2008	£595	19 %
China Anesthesia Apparatus Market Report 2008	April 2008	£665	19 %
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration:A Guidebook of Registration Application for Imported Chemical Drugs China Pharmaceutical Guidebook Series (2) (3rd edition)	October 2009	£495	19 %
Keryx Biopharmaceuticals: Premium Company Profile	February 2008	£175	19 %
EGIS Pharmaceuticals Plc - SWOT Analysis	February 2008	£44	19 %
Morocco Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	19 %
Merck & Co: Pipeline Products Performance Potential	November 2009	£595	19 %
Ratiopharm direct GmbH - Strategic Analysis Review	March 2009	£83	19 %
Alcon Medical Device Company Intelligence Report	November 2009	£295	19 %
Premium Company Profile: GTx, Inc.	November 2007	£175	19 %
Biosimilars Evolution or Revolution	September 2006	£1950	19 %
Ukraine Pharma - New Opportunities for Growth	November 2008	£530	18.9 %
Merck & Co., Inc. Pharmavitae Profile	December 2007	£1980	18.9 %
Wound Treatments in South Korea	January 2009	£560	18.9 %
Eye Care in South Korea	January 2009	£560	18.9 %
Gilead Sciences Inc. Pharmavitae Profile	December 2007	£1990	18.9 %
Abbott Laboratories Pharmavitae Profile	December 2007	£1980	18.9 %
The True State of the Pharmaceutical Industry	December 2008	£495	18.9 %
China Pharmaceutical Chain Industry Report, 2006	August 2006	£990	18.9 %
Pfizer Inc. Pharmavitae Profile	December 2007	£1980	18.9 %
Amgen Inc. Pharmavitae Profile	December 2007	£1980	18.9 %
Eye Care in Israel	July 2008	£450	18.9 %
Kyowa Hakko Kirin IMS Company Profile	November 2008	£510	18.55 %
Valeant IMS Company Profile	May 2007	£249	18.55 %
Actavis IMS Company Profile	September 2006	£249	18.55 %
Menarini	July 2008	£510	18.55 %
Forest IMS Company Profile	September 2006	£249	18.55 %
Allergan IMS Company Profile	September 2006	£3000	18.55 %
Zentiva IMS Company Profile	October 2008	£510	18.55 %
HLR IMS Company Profile	December 2008	£510	18.55 %
Meiji Seika IMS Company Profile	December 2008	£510	18.55 %
GlaxoSmithKline IMS Company Profile	September 2006	£249	18.55 %
Ono IMS Company Profile	December 2008	£510	18.55 %
Ostuka IMS Company Profile	December 2008	£510	18.55 %
Allergan IMS Company Profile	June 2008	£510	18.55 %
Sepracor	July 2008	£510	18.55 %
Wyeth IMS Company Profile	February 2009	£510	18.55 %
Johnson IMS Company Profile	December 2008	£510	18.55 %
Shire	July 2008	£510	18.55 %
Schwarz Pharma IMS Company Profile	October 2006	£249	18.55 %
Novartis IMS Company Profile	December 2008	£510	18.55 %
Schering AG IMS Company Profile	November 2006	£249	18.55 %
Digestive Remedies in South Korea	January 2009	£560	18.55 %
MundiPharma IMS Company Profile	November 2008	£510	18.55 %
Meji Seika IMS Company Profile	November 2006	£249	18.55 %
Apotex IMS Company Profile	August 2009	£510	18.55 %
Lundbeck IMS Company Profile	November 2008	£510	18.55 %
Bayer Company Profile	May 2007	£249	18.55 %
Baxter IMS Company Profile	May 2007	£249	18.55 %
Recordati IMS Company Profile	June 2008	£510	18.55 %
UCB IMS Company Profile	May 2008	£510	18.55 %
Menarini IMS Company Profile	August 2009	£510	18.55 %
Pierre Fabre IMS Company Profile	June 2008	£510	18.55 %
Eisai IMS Company Profile	August 2009	£510	18.55 %
Astellas IMS Company Profile	August 2009	£510	18.55 %
AstraZeneca IMS Company Profile	August 2009	£510	18.55 %
Fresenius IMS Company Profile	October 2008	£510	18.55 %
Ferring IMS Company Profile	December 2008	£510	18.55 %
Stada IMS Company Profile	September 2006	£249	18.55 %
Bristol-Myers Squibb IMS Company Profile	February 2009	£510	18.55 %
Gruenenthal IMS Company Profile	October 2006	£249	18.55 %
SkyePharma IMS Company Profile	September 2006	£249	18.55 %
Pfizer IMS Company Profile	July 2008	£510	18.55 %
Mitsubishi Pharma IMS Company Profile	September 2006	£249	18.55 %
Ono IMS Company Profile	September 2006	£249	18.55 %
ISIS IMS Company Profile	November 2008	£510	18.55 %
Johnson & Johnson IMS Company Profile	August 2009	£510	18.55 %
Sigma-Tau IMS Company Profile	August 2009	£510	18.55 %
Chiesi IMS Company Profile	August 2008	£510	18.55 %
Par Pharmaceutical IMS Company Profile	October 2008	£510	18.55 %
Analgesics in South Korea	January 2009	£560	18.55 %
King Pharmaceuticals IMS Company Profile	October 2008	£510	18.55 %
Procter & Gamble IMS Company Profile	October 2008	£510	18.55 %
Merck KGaA IMS Company Profile	September 2006	£249	18.55 %
Kyowa Hakko IMS Company Profile	November 2006	£249	18.55 %
Sanofi-Aventis IMS Company Profile	August 2009	£510	18.55 %
Nycomed Pharma IMS Company Profile	June 2008	£510	18.55 %
Taisho IMS Company Profile	May 2006	£249	18.55 %
Mylan IMS Company Profile	June 2008	£510	18.55 %
Gilead Sciences IMS Company Profile	June 2008	£510	18.55 %
Daiichi Sankyo	July 2008	£510	18.55 %
Barr Laboratories IMS Company Profile	June 2008	£510	18.55 %
Vitamins and Dietary Supplements in South Korea	January 2009	£560	18.55 %
Eye Care in Egypt	September 2008	£560	18.55 %
Astellas	July 2008	£510	18.55 %
Solvay IMS Company Profile	May 2008	£510	18.55 %
Gedeon Richter	July 2008	£510	18.55 %
Gruenenthal	July 2008	£510	18.55 %
Johnson & Johnson: PharmaVitae Profile Healthcare	July 2009	£3765	18.55 %
Shionogi IMS Company Profile	December 2008	£510	18.55 %
Biovail IMS Company Profile	August 2009	£510	18.55 %
Chugai IMS Company Profile	May 2008	£510	18.55 %
Boehringer Ingelheim IMS Company Profile	November 2008	£510	18.55 %
Wound Treatments in Israel	July 2008	£450	18.55 %
Eisai	July 2008	£510	18.55 %
Otsuka IMS Company Profile	June 2006	£249	18.55 %
LEO Pharma	July 2008	£510	18.55 %
Cephalon IMS Company Profile	August 2009	£510	18.55 %
Boehringer Ingelheim	July 2008	£510	18.55 %
Commercial Insight: CNS Market Overview Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors	April 2008	£5285	18.5 %
Snapshots Poland OTC Pharmaceuticals 2007	September 2007	£0	18.5 %
Pipeline Insight: Molecular Targeted Cancer Therapies Can anything else revolutionize the market? - Cancer	October 2007	£5020	18.5 %
Snapshots Poland OTC Pharmaceuticals 2007	September 2007	£0	18.5 %
Snapshots Poland OTC Pharmaceuticals 2007	September 2007	£150	18.5 %
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder (ADHD)	November 2006	£795	18.5 %
Vitamins And Dietary Supplements in Egypt	September 2008	£560	18.2 %
Mylan IMS Company Profiles	June 2009	£510	18.2 %
Acambis IMS Company Profile	December 2006	£510	18.2 %
Novo Nordisk IMS Company Profile	July 2009	£510	18.2 %
Vitamins And Dietary Supplements in Israel	July 2008	£450	18.2 %
NRT Smoking Cessation Aids in Israel	July 2008	£450	18.2 %
GlaxoSmithKline IMS Company Profile	September 2009	£510	18.2 %
Dr Reddy's IMS Company Profile	January 2007	£249	18.2 %
3M IMS Company Profile	December 2006	£249	18.2 %
Abbott IMS Company Profile	July 2009	£510	18.2 %
Par IMS Company Profile	September 2009	£510	18.2 %
UCB IMS Company Profiles	June 2009	£510	18.2 %
Smoking Cessation Aids in Japan	October 2005	£450	18.2 %
Dr Reddy's IMS Company Profile	January 2007	£249	18.2 %
Wound Treatments in Taiwan	June 2008	£450	18.2 %
Cough, Cold and Allergy (Hay Fever) Remedies in South Korea	January 2009	£560	18.2 %
Solvay IMS Company Profiles	June 2009	£510	18.2 %
Genentech IMS Company Profile	April 2009	£510	18.2 %
Pfizer IMS Company Profiles	June 2009	£510	18.2 %
Millennium IMS Company Profile	January 2007	£510	18.2 %
Boehringer Ingelheim IMS Company Profiles	June 2009	£510	18.2 %
Roche IMS Company Profiles	June 2009	£510	18.2 %
Dr Reddy's IMS Company Profile	January 2007	£249	18.2 %
Baxter IMS Company Profiles	June 2009	£510	18.2 %
Lilly IMS Company Profile	July 2009	£510	18.2 %
Kowa IMS Company Profile	December 2006	£510	18.2 %
Almirall IMS Company Profile	July 2009	£510	18.2 %
Bausch & Lomb IMS Company Profile	December 2006	£249	18.2 %
Nycomed IMS Company Profile	July 2009	£510	18.2 %
Pfizer IMS Company Profile	July 2009	£510	18.2 %
ratiopharm IMS Company Profile	January 2007	£249	18.2 %
Endo Pharmaceuticals IMS Company Profile	January 2007	£249	18.2 %
Watson IMS Company Profile	September 2009	£510	18.2 %
Takeda IMS Company Profile	September 2009	£510	18.2 %
Zentiva Company Profile	January 2007	£249	18.2 %
Esteve IMS Company Profile	July 2009	£510	18.2 %
Wound Treatments in Egypt	September 2008	£560	18.2 %
Actavis IMS Company Profile	September 2009	£510	18.2 %
Roche IMS Company Profile	April 2009	£510	18.2 %
Amgen IMS Company Profile	July 2009	£510	18.2 %
Nestle IMS Company Profile	April 2009	£510	18.2 %
Bayer IMS Company Profile	April 2009	£510	18.2 %
Merck & Co IMS Company Profile	September 2009	£510	18.2 %
Daiichi Sankyo IMS Company Profile	July 2009	£510	18.2 %
Servier IMS Company Profile	September 2009	£510	18.2 %
Teva IMS Company Profile	September 2009	£510	18.2 %
Analgesics in Egypt	September 2008	£560	18.2 %
Analgesics in Israel	July 2008	£450	18.2 %
Schering-Plough IMS Company Profile	April 2009	£510	18.2 %
Medicated Skin Care in Sweden	October 2007	£450	18.2 %
Digestive Remedies in Israel	July 2008	£450	18.2 %
NRT Smoking Cessation Aids in South Korea	January 2009	£560	18.2 %
The Gastrointestinal Market Outlook To 2012	October 2007	£1495	18.2 %
Vitamins and Dietary Supplements in Taiwan	June 2008	£450	18.2 %
Shire IMS Company Profile	September 2009	£510	18.2 %
Elan IMS Company Profile	April 2009	£510	18.2 %
Serono IMS Company Profile	December 2006	£249	18.2 %
Human Genome Sciences IMS Company Profile	September 2009	£510	18.2 %
Biogen Idec IMS Company Profile	July 2009	£510	18.2 %
Taisho IMS Company Profile	February 2007	£249	18.2 %
Ipsen IMS Company Profile	July 2009	£510	18.2 %
Genzyme IMS Company Profile	September 2009	£510	18.2 %
Generic Drug Market in Canada	August 2009	£795	18.2 %
Eye Care in Taiwan	June 2008	£450	18.2 %
Flow Cytometers A Global Market Perspective	November 2009	£1980	18 %
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products China Pharmaceutical Guidebook Series (4) (3rd edition)	October 2009	£495	18 %
Axcan Pharma Inc Premium Company Profile	December 2007	£175	18 %
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration:A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines China Pharmaceutical Guidebook Series (3) (3rd edition)	October 2009	£495	18 %
China Pharmaceuticals 2005	October 2005	£150	18 %
Stakeholder Opinions: Fibromyalgia Potentially lucrative market soon to become reality	May 2007	£1325	18 %
Drug Delivery Technologies Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies	September 2008	£2310	18 %
Drug Delivery Technologies: Players, products & prospects to 2015	November 2007	£1795	18 %
China Senile Dementia Drug Market Report The Chinese Dementia Drug Utilization	March 2009	£5285	18 %
Par Pharmaceutical Companies, Inc. - Financial and Strategic Analysis Review	June 2009	£83	18 %
Pipeline Insight: Molecular Targeted Cancer Therapies More pipeline activity, less product differentiation	November 2008	£5285	18 %
Pharmacoeconomics and Health Outcomes Driving Formulary Access and Reimbursement	May 2007	£2905	18 %
F. Dohmen Co., The - SWOT Analysis	January 2009	£44	18 %
The Global HIV/Aids Market Outlook To 2012	July 2007	£1495	18 %
US Launch Phase IIIA, Phase IIIB and Launch Year Brand Commercialization	December 2006	£5080	18 %
The F. Dohmen Co. SWOT Analysis	November 2008	£44	18 %
China Pharmaceutical Industry Report (Merger and Reorganization), 2006-2007	January 2007	£1125	18 %
Prescribing Data Restriction Program (PDRP), The Critical Assessment and Best Practices	September 2006	£990	18 %
Medicated Skin Care in South Korea	January 2009	£560	17.85 %
Digestive Remedies in Egypt	September 2008	£560	17.85 %
Medicated Skin Care in Russia	November 2007	£450	17.85 %
NRT Smoking Cessation Aids in Japan	June 2006	£450	17.85 %
Analgesics in Taiwan	June 2008	£450	17.85 %
Winning Pharmaceutical Brand Management Maximizing brand value through best practice in brand development and product marketing	March 2006	£1495	17.85 %
Digestive Remedies in Taiwan	June 2008	£450	17.85 %
Falling Margins in Pharma - increasing ROI through CRM (Market Focus)	July 2007	£660	17.85 %
Cough, Cold and Allergy (Hay Fever) Remedies in Israel	July 2008	£450	17.85 %
Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile	March 2009	£1990	17.5 %
Eye Care in Vietnam	April 2009	£560	17.5 %
Sciele Pharma, Inc. - SWOT Analysis	December 2008	£44	17.5 %
Medicated Skin Care in Portugal	January 2008	£450	17.5 %
Salix Pharmaceuticals,Ltd. - SWOT Analysis	December 2008	£44	17.5 %
Wound Treatments in Vietnam	April 2009	£560	17.5 %
McKesson Corporation - SWOT Analysis	October 2008	£44	17.5 %
Eye Care in Japan	September 2007	£450	17.5 %
NRT Smoking Cessation Aids in Taiwan	June 2008	£450	17.5 %
Sawai Pharmaceuticals Generics Company Intelligence Report Company Intelligence Report	March 2009	£195	17.5 %
The Future of Contract Manufacturing Market Forecasts to 2015	December 2009	£2310	17.5 %
Global Pharmaceutical Markets	January 2008	£3205	17.5 %
AstraZeneca plc: PharmaVitae Profile	September 2009	£3765	17.5 %
Medicated Skin Care in Japan	September 2007	£450	17.5 %
Hospira Inc - SWOT Analysis	August 2009	£83	17.5 %
Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems	September 2009	£1980	17.5 %
Abbott Laboratories Pipeline Products Performance Potential	July 2008	£595	17.5 %
Vaccines The World Market	February 2007	£2640	17.5 %
Watson Pharmavitae Generics Profile	September 2007	£1325	17.5 %
Pipeline Insight: Therapeutic Cancer Vaccines A turbulent path from bench to bedside	December 2006	£3965	17.5 %
Neurodegenerative Market Forecast to 2013	February 2009	£6600	17.5 %
Wound Treatment in China	December 2005	£450	17.5 %
The Outlook for Pharmaceuticals in Northern Europe	March 2007	£1995	17.5 %
Medicated Skin Care in Egypt	September 2008	£560	17.5 %
Medicated Skin Care in Israel	July 2008	£450	17.5 %
Cough, Cold and Allergy (hay Fever) Remedies in Egypt	September 2008	£560	17.5 %
Vaccines: The World Market	February 2007	£2640	17.5 %
Cough, Cold and Allergy (Hay Fever) Remedies in Taiwan	June 2008	£450	17.5 %
Pharmaceutical Distribution in the US Current and Future Perspectives	July 2009	£1495	17.15 %
Pharmaceutical Market Trends, 2008 - 2012 Key market forecasts and growth opportunities (3rd Edition)	November 2008	£1350	17.15 %
Digestive Remedies in Vietnam	April 2009	£560	17.15 %
Menarini: PharmaVitae Profile	March 2009	£1990	17.15 %
China Pharmaceutical Market Report 2009	January 2009	£340	17.15 %
China Pharmaceutical Regulatory Report 2009	January 2009	£1020	17.15 %
Abbott Laboratories: PharmaVitae Profile Healthcare	September 2009	£3765	17.15 %
Pfizer Inc.: PharmaVitae Profile	July 2009	£3765	17.15 %
GlaxoSmithKline plc: PharmaVitae Profile	October 2009	£3765	17.15 %
Analgesics in Vietnam	April 2009	£560	17.15 %
Russian Pharma Sector Analysis (2007)	August 2007	£725	17.15 %
Pharmaceutical Licensing Strategies Best practices in deal-making, valuations and strategic management	June 2006	£1495	17.15 %
CNS Biomarkers: Players, products and prospects (Volume II)	August 2008	£595	17.15 %
The Pharmaceutical Company Outlook to 2011 Financial and Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech	December 2006	£2640	17 %
Chugai Pharmaceutical Co. Ltd - Financial and Strategic Analysis Review	April 2009	£83	17 %
Teva Pharmaceutical Industries Limited - Financial and Strategic Analysis Review	July 2009	£83	17 %
Watson Pharmaceuticals, Inc. - SWOT Analysis	December 2008	£44	17 %
Indication Expansion Opportunities for successful lifecycle management	March 2007	£1495	17 %
The US Pharmaceutical Market 2009-2024	November 2009	£1499	17 %
Warner Chilcott Limited - SWOT Analysis	August 2009	£83	17 %
Rimonabant: The first of the Cannabinoid blockbusters	June 2007	£1499	17 %
King Pharmaceuticals, Inc SWOT Analysis	November 2008	£44	17 %
Allergan: Pipeline , Products , Performance , Potential	February 2008	£595	16.8 %
Pharmaceutical Contract Manufacturing Global Market Trends	November 2009	£1980	16.8 %
Eye Care in Slovakia	July 2006	£450	16.8 %
Amgen Inc.: PharmaVitae Profile Healthcare	July 2009	£3765	16.8 %
UCB: Pipeline - Products - Performance - Potential	January 2010	£595	16.8 %
Wound Treatments in Slovakia	July 2006	£450	16.8 %
Analgesics in Slovakia	July 2006	£450	16.8 %
AstraZeneca Plc PharmaVitae Profile	July 2008	£1980	16.8 %
Cough, Cold and Allergy (Hay Fever) Remedies in Vietnam	April 2009	£560	16.8 %
The Turkish Pharmaceutical Market Outlook to 2014 Policy environment, market structure, competitive landscape, growth opportunities	January 2010	£3835	16.8 %
UCB Prospects to 2010	November 2008	£595	16.8 %
Johnson & Johnson PharmaVitae Profile	July 2008	£1980	16.8 %
Caliper Life Sciences Inc. - Financial and Strategic Analysis Review	June 2009	£83	16.5 %
Snapshots China Pharmaceuticals 2005	October 2005	£150	16.5 %
Medicis Pharmaceutical Corporation - Financial and Strategic Analysis Review	June 2009	£83	16.5 %
Retail Clinics, The Emerging Market for Convenience and In-Store Healthcare	September 2007	£1980	16.5 %
Eisai: Pipeline, Products, Performance, Potential	November 2009	£595	16.5 %
Germany Pharmaceuticals and Healthcare Report Q2 2009	April 2009	£250	16.5 %
Premium Company Profile Barrier Therapeutics	October 2007	£175	16.5 %
Premium Company Profile Antares Pharma	November 2007	£175	16.5 %
Allergan, Inc. - SWOT Analysis	June 2008	£44	16.5 %
Spain Pharmaceuticals 2005	October 2005	£150	16.5 %
Directed Molecular Evolution Product lifecycle management for biologics	May 2006	£2640	16.5 %
Brazil Pharmaceuticals 2005	October 2005	£150	16.5 %
West Pharmaceutical Services, Inc. - Financial and Strategic Analysis Review	June 2009	£83	16.5 %
Biovail Corp - Financial and Strategic Analysis Review	June 2009	£83	16.5 %
Latvia Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	16.5 %
France Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	16.5 %
Premium Company Profile Auxilium Pharmaceuticals	November 2007	£175	16.5 %
Vitamins and Dietary Supplements in Slovakia	July 2006	£450	16.45 %
Medicated Skin Care in Vietnam	April 2009	£560	16.45 %
Analgesics in Saudi Arabia	June 2006	£450	16.45 %
Wound Treatments in Brazil	August 2007	£450	16.45 %
Solvay Prospects to 2010 Pipeline, Products,Performance,Potential	December 2008	£595	16.45 %
Shire: Pipeline • Products • Performance • Potential	December 2008	£595	16.45 %
Vitamins and Dietary Supplements in Vietnam	April 2009	£560	16.45 %
Wound Treatments in Hong Kong	March 2006	£450	16.1 %
Digestive Remedies in Saudi Arabia	June 2006	£450	16.1 %
Egypt Wound Care Management Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1980	16.1 %
Shionogi & Co., Ltd Pharmavitae Profile	December 2007	£1990	16.1 %
Digestive Remedies in Slovakia	July 2006	£450	16.1 %
Enzyme Replacement & Enhancement Therapies (ERT) Competitor Analysis	November 2008	£225	16.1 %
Vitamins And Dietary Supplements in Saudi Arabia	June 2006	£450	16.1 %
AstraZeneca: Pipeline, Products, Performance, Potential	November 2007	£595	16.1 %
Major Pharmaceutical Markets of the Middle East An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE (2nd Ed)	February 2009	£1295	16.1 %
Russian Pharma Sector Forecast to 2013	February 2010	£725	16.1 %
Wound Treatment in South Korea	December 2005	£450	16.1 %
Les Laboratoires Servier: PharmaVitae Profile	October 2008	£1990	16.1 %
Cough, Cold and Allergy (Hayfever) Remedies in China	December 2005	£450	16.1 %
NRT Smoking Cessation Aids in Saudi Arabia	June 2006	£450	16.1 %
NRT Smoking Cessation Aids in Slovakia	July 2006	£450	16.1 %
Five factors that will shape the future of the pharmaceutical industry	October 2006	£590	16.1 %
Sciele Pharma, Inc. - Financial and Strategic Analysis Review	April 2009	£83	16 %
Caraco Pharmaceutical Laboratories Ltd -Financial Company Report	February 2008	£115	16 %
Simcere Pharmaceutical Group. -Financial Company Report	February 2008	£115	16 %
Lithuania Pharmaceuticals and Healthcare Report Q4 2008	October 2008	£425	16 %
Alliance Pharmaceutical Corp. - Financial and Strategic Analysis Review	April 2009	£83	16 %
Premium Company Profile: Pharmion Corporation	November 2007	£175	16 %
Skystar Bio -Pharmaceutical Company Co., Ltd. -Financial Company Report	February 2008	£115	16 %
Teva Pharmaceutical Industries Ltd -Financial Company Report	February 2008	£115	16 %
Benda Pharmaceutical, Inc -Financial Company Report	February 2008	£115	16 %
BioMarin Pharmaceutical Inc. - Financial and Strategic Analysis Review	June 2009	£83	16 %
Lebanon Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	16 %
Snapshots Spain Pharmaceuticals 2007	June 2007	£150	16 %
Forest Laboratories, Inc. - Financial and Strategic Analysis Review	April 2009	£83	16 %
Ono Pharmaceutical Co., Ltd. - Financial and Strategic Analysis Review	July 2009	£83	16 %
Hospira, Inc. - Financial and Strategic Analysis Review	July 2009	£83	16 %
Top 10 Biotech Companies Market Outlook, 2008-2023	December 2008	£1499	16 %
Report on China's Anti-fungal Drug Industry	December 2006	£200	16 %
Bactolac Pharmaceutical Inc. -Financial Company Report	February 2008	£115	16 %
Medicis Pharmaceutical Corp -Financial Company Report	February 2008	£115	16 %
Snapshots Spain Pharmaceuticals 2007	June 2007	£150	16 %
Snapshots Spain Pharmaceuticals 2007	June 2007	£150	16 %
Snapshots Poland Pharmaceuticals 2007	August 2007	£150	16 %
La Jolla Pharmaceutical Co -Financial Company Report	February 2008	£115	16 %
Yakult Honsha Co., Ltd. - Financial and Strategic Analysis Review	July 2009	£83	16 %
Taro Pharmaceutical Industries Ltd -Financial Company Report	February 2008	£115	16 %
The Pharmaceutical Market Czech Republic	May 2008	£595	16 %
Catalyst Pharmaceutical Partners Inc. -Financial Company Report	February 2008	£115	16 %
Huifeng Bio -Pharmaceutical Technology, Inc. -Financial Company Report	February 2008	£115	16 %
Pharmaceutical Product Development Inc -Financial Company Report	February 2008	£115	16 %
IMCOR Pharmaceutical Co. -Financial Company Report	February 2008	£115	16 %
Dragon Pharmaceutical Inc -Financial Company Report	February 2008	£115	16 %
Belgium Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	16 %
LAM Pharmaceutical Corp -Financial Company Report	February 2008	£115	16 %
Dov Pharmaceutical Inc -Financial Company Report	February 2008	£115	16 %
KV Pharmaceutical Co. -Financial Company Report	February 2008	£115	16 %
BioMarin Pharmaceutical Inc -Financial Company Report	February 2008	£115	16 %
Nymox Pharmaceutical Corporation -Financial Company Report	February 2008	£115	16 %
Premium Company Profile Santarus	October 2007	£175	16 %
RNA therapy: the next big thing after monoclonal antibodies?	October 2008	£2640	16 %
Nastech Pharmaceutical Co Inc -Financial Company Report	February 2008	£115	16 %
Chugai Pharmaceutical Co Ltd -Financial Company Report	February 2008	£115	16 %
Pipeline and Commercial Insight: Nicotine Dependence - Chantix issues overshadow vaccine potential Healthcare	March 2009	£5285	16 %
Par Pharmaceutical Companies Inc -Financial Company Report	February 2008	£115	16 %
Alliance Pharmaceutical Corporation -Financial Company Report	February 2008	£115	16 %
Snapshots Egypt Pharmaceuticals 2009	May 2009	£300	16 %
Market Development in Anti-virals What is Next?	August 2004	£445	16 %
Pharmaceutical Distribution in Europe The Emergence of Direct-to-Pharmacy Supply	February 2008	£995	15.75 %
Bristol-Myers Squibb Co. Pharmavitae Profile	December 2007	£1980	15.75 %
Wound Treatments in Thailand	November 2007	£450	15.75 %
Novartis AG: PharmaVitae Profile	July 2009	£3765	15.75 %
Smoking Cessation Aids in South Korea	December 2005	£450	15.75 %
Global Pharmaceutical Market Forecast to 2012	October 2008	£1190	15.75 %
Astellas Pharma Inc.: PharmaVitae Profile	February 2009	£1990	15.75 %
Wound Treatments in Sweden	October 2007	£450	15.75 %
Vitamins and Dietary Supplements in Hong Kong	October 2007	£450	15.75 %
The Pharmaceutical Industry Key events and trends shaping its current status and future direction	March 2006	£2435	15.75 %
Italy Generics Market Intelligence Report	March 2006	£295	15.75 %
United States Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	15.75 %
Biogen Idec Inc.: PharmaVitae Profile	March 2009	£1990	15.75 %
Global Pharmaceuticals - Yearly Update 2006	July 2007	£600	15.75 %
Shionogi: Pipeline - Products - Performance - Potential	April 2008	£595	15.5 %
Daiichi Sankyo: Pipeline, Products, Performance, Potential	June 2008	£595	15.5 %
Mission Pharmacal Company - SWOT Analysis	October 2008	£44	15.5 %
Czech Republic Pharmaceuticals and Healthcare Report Q1 2009	February 2009	£250	15.5 %
Watson Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	15.5 %
Javelin Pharmaceuticals Inc Premium Company Profile	April 2008	£175	15.5 %
Boehringer Ingelheim: Pipeline, Products, Performance, Potential	April 2008	£595	15.5 %
Snapshots Saudi Arabia Pharmaceuticals 2009	May 2009	£300	15.5 %
Asahi Kasei Corporation - Financial and Strategic Analysis Review	July 2009	£83	15.5 %
Snapshots Brazil Pharmaceuticals 2006	November 2006	£150	15.5 %
South Korea Pharmaceuticals and Healthcare Report Q3 2007	May 2009	£250	15.5 %
Takeda: Pipeline, Products, Performance, Potential	November 2007	£595	15.5 %
Pozen Inc Premium Company Profile	December 2007	£175	15.5 %
Shionogi Pipeline, Products, Performance, Potential	April 2008	£595	15.5 %
Takeda Pharmaceutical Company Limited - Financial and Strategic Analysis Review	July 2009	£83	15.5 %
Snapshots UK Pharmaceuticals 2006	November 2006	£150	15.5 %
Snapshots Mexico Pharmaceuticals 2007	July 2007	£150	15.5 %
Shire: Pipeline \| Products \| Performance \| Potential	May 2008	£595	15.5 %
La Jolla Pharmaceutical Company - Financial and Strategic Analysis Review	June 2009	£83	15.5 %
Taro Pharmaceuticals Industries Ltd - SWOT Analysis	October 2008	£44	15.5 %
Stakeholder Opinions: Systemic Lupus Erythematosus Market Set to Enter Era of Biologic Therapies	March 2008	£1355	15.5 %
Women's Reproductive Disorders Therapeutics 2008-2018	September 2008	£1499	15.5 %
Snapshots Brazil Pharmaceuticals 2007	July 2007	£150	15.5 %
PSS World Medical, Inc. - Financial and Strategic Analysis Review	July 2009	£83	15.5 %
Switzerland Generics Market Intelligence Report	May 2006	£295	15.5 %
Inflammatory Directions Strategies for Six Diseases with Unmet Needs	April 2008	£745	15.5 %
Cough, Cold and Allergy (Hay Fever) Remedies in Slovakia	July 2006	£450	15.4 %
Pharmaceutical Management Team, The The Roles, Responsibilities, and Leadership Strategies of CEOs, CTOs, Marketing Executives, and HR Leaders	March 2006	£33	15.4 %
Lundbeck Pharmaceutical Company Intelligence Report Performance, Products, Pipeline and Potential	March 2009	£595	15.4 %
Roche: Pipeline, Products, Performance, Potential	November 2007	£595	15.4 %
Parkinson's Disease Market analysis and forecasts 2008-2012, 2017 & 2022	January 2008	£1499	15.4 %
Eye Care in China	July 2008	£450	15.4 %
OTC Healthcare in United Arab Emirates	November 2008	£750	15.4 %
Booming US Generic Drug Market	August 2009	£795	15.4 %
Takeda Pharmaceutical Co., Ltd Pharmavitae Profile	December 2007	£1990	15.4 %
Medicated Skin Care in Slovakia	July 2006	£450	15.4 %
Novo Nordisk A/S: PharmaVitae Profile	July 2008	£1980	15.4 %
Puerto Rico Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	15.4 %
China Asthma Drug Market Report The Chinese Asthma Drug Drug Utilization	May 2009	£2970	15.4 %
Eli Lilly & Co. Pharmavitae Profile	December 2007	£1980	15.4 %
Les Laboratoires Servier Pharmavitae Profile	December 2007	£1990	15.4 %
Puerto Rico Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	15.4 %
Evaluating Business Intelligence Opportunities in the Pharmaceutical Industry (Strategy Focus)	June 2007	£660	15.4 %
Dainippon Sumitomo Pharma Co., Ltd Pharmavitae Profile	December 2007	£1980	15.4 %
Wound Treatments in China	July 2008	£450	15.4 %
The Pharmaceutical Market Taiwan	May 2008	£595	15.05 %
Menarini Pharmavitae Profile	December 2007	£1980	15.05 %
Vitamins and Dietary Supplements in Venezuela	February 2008	£450	15.05 %
Eisai Co., Ltd Pharmavitae Profile	December 2007	£1990	15.05 %
Pharma Sales World 2007: Advanced Sales Force Remodelling Strategies in a Multi-Channel Environment	January 2008	£75	15.05 %
Astrazeneca Plc (Incl. Medimmune Inc.) Pharmavitae Profile	December 2007	£1990	15.05 %
NRT Smoking Cessation Aids in Brazil	August 2007	£450	15.05 %
H. Lundbeck A/S Pharmavitae Profile	December 2007	£1980	15.05 %
The Japanese Pharmaceutical Market Outlook to 2014 Policy environment, market structure, competitive landscape, growth opportunities	January 2010	£3835	15.05 %
Astellas Pharma Inc. Pharmavitae Profile	December 2007	£1990	15.05 %
Nanotechnology in Health Care	February 2007	£2970	15.05 %
Effective Deal Making in Drug Delivery	April 2009	£3594	15.05 %
Vitamins and Dietary Supplements in China	July 2008	£450	15.05 %
The Pharmaceutical Market Taiwan	May 2008	£595	15.05 %
NRT Smoking Cessation Aids in China	July 2008	£450	15.05 %
Bayer Schering Pharma AG: PharmaVitae Profile	July 2009	£3765	15.05 %
Wound Treatment in Taiwan	December 2005	£450	15.05 %
Sepracor Inc. Pharmavitae Profile	December 2007	£1980	15.05 %
Cough, Cold and Allergy (Hayfever) Remedies in South Korea	December 2005	£450	15.05 %
The Indian Pharmaceutical Market to 2011 Competitive dynamics and major players	July 2007	£1495	15.05 %
The World OTC Pharmaceutical Market Analysis & Forecasts, 2008-2023	June 2008	£1499	15.05 %
F. Hoffmann-La Roche Ltd.: PharmaVitae Profile	July 2009	£3765	15.05 %
Zentiva Generics Company Intelligence Report Company Intelligence Report	March 2009	£195	15.05 %
Sales Force Effectiveness	September 2008	£2640	15.05 %
Latin American Pharmaceutical Market Outlook To 2014 Policy environment, market analysis, forecasts and growth opportunities	November 2009	£3835	15.05 %
Latin American Developing Markets for Pharmaceuticals, 2006-2011	November 2006	£1999	15.05 %
Medicated Skin Care in China	July 2008	£450	15.05 %
Barrier Therapeutics, Inc. - SWOT Analysis	September 2008	£44	15 %
Pipeline Insight: Cancer Overview Increasing Diversity Offers Both High Risk And Reward	September 2007	£5020	15 %
The Cancer Market Outlook To 2014 Competitive landscape, market size, pipeline analysis and growth opportunities	January 2010	£3835	15 %
Akorn, Inc - Financial and Strategic Analysis Review	June 2009	£83	15 %
Effectively Selling Medical Devices in Europe	June 2007	£295	15 %
MicroReaction Technology, Reports - Lifesciences	February 2007	£2680	15 %
Lannett Company, Inc. - Financial and Strategic Analysis Review	April 2009	£83	15 %
The OTC Animal Health Global Market Opportunity	January 2007	£895	15 %
New Drug Futures	May 2006	£2995	15 %
Global Tuberculosis Strategies	June 2007	£2640	15 %
Hungary Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	15 %
Nitromed, Inc Premium Company Profile	December 2007	£175	15 %
Shire Plc Pharmavitae Profile	December 2007	£1980	14.7 %
Merck Serono S.A. Pharmavitae Profile	December 2007	£1990	14.7 %
Altana Pharmaceutical Company Intelligence Report	August 2006	£795	14.7 %
The Global Pain Market 2008-2023	November 2008	£1499	14.7 %
Eli Lilly & Co.: PharmaVitae Profile	July 2009	£3765	14.7 %
Eye Care in Indonesia	April 2009	£560	14.7 %
UCB S.A.: PharmaVitae Profile	March 2009	£1990	14.7 %
Central and Eastern European (CEE) Developing Markets for Pharmaceuticals, 2006-2011	November 2006	£1999	14.7 %
Commercial Insight: Antihormonal Cancer Therapies	July 2009	£10040	14.7 %
Nycomed A/S: PharmaVitae Profile	March 2009	£1990	14.7 %
Pharmaceutical Strategic Alliances Maximizing returns from collaborative development and commercialization	September 2006	£1495	14.7 %
Forest Laboratories Inc.: PharmaVitae Profile	November 2008	£1990	14.7 %
OTC Healthcare - Uzbekistan	April 2009	£750	14.7 %
Optimizing Sales Force Effectiveness - From quantity to quality From quantity to quality	November 2006	£2640	14.7 %
Boehringer Ingelheim GmbH: PharmaVitae Profile	March 2009	£1990	14.7 %
Daiichi Sankyo: PharmaVitae Profile PharmaVitae Profile	January 2007	£1980	14.7 %
NRT Smoking Cessation Aids in Chile	July 2007	£450	14.7 %
Gastrointestinal Drug Discoveries	January 2008	£995	14.7 %
Boehringer Ingelheim Gmbh Pharmavitae Profile	December 2007	£1990	14.7 %
Wound Treatments in Indonesia	April 2009	£560	14.7 %
Eye Care in Thailand	July 2008	£450	14.7 %
Premium Company Profile: Depomed	November 2007	£175	14.5 %
Inyx, Inc. - Financial and Strategic Analysis Review	April 2009	£83	14.5 %
Merck KGaA Pipeline ,Products ,Performance ,Potential	September 2008	£595	14.5 %
Bulgaria Pharmaceuticals & Healthcare	December 2006	£395	14.5 %
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The Challenge Of Turning Technology Into Therapy	July 2007	£1999	14.5 %
Pipeline Insight: Insulin Antidiabetics Return to Injections Alternative Delivery Methods Fall by The Wayside	July 2008	£3965	14.5 %
AMDL, Inc. - Financial and Strategic Analysis Review	June 2009	£83	14.5 %
World Diabetes Market, The 2005-2011	March 2006	£1499	14.5 %
Indevus Pharmaceuticals Premium Company Profile	December 2007	£175	14.5 %
Antihormonal Therapies Market Forecast	July 2009	£10040	14.5 %
Mylan Laboratories Inc SWOT Analysis	November 2008	£44	14.5 %
Warner Chilcott Ltd Premium Company Profile	January 2008	£175	14.5 %
Mylan Laboratories Inc - SWOT Analysis	November 2008	£44	14.5 %
Supergen Inc Premium Company Profile	December 2007	£175	14.5 %
Premium Company Profile Gedeon Richter	October 2007	£175	14.5 %
Premium Company Profile CV Therapeutics	October 2007	£175	14.5 %
Pakistan Pharmaceuticals and Healthcare Report Q1 2009	January 2009	£250	14.5 %
Pharmaceutical Product Launch Evaluation Excellence Processes and Measures to Evaluate Launch Success	November 2008	£2980	14.5 %
World Diabetes Market Analysis 2009-2023	February 2009	£1499	14.5 %
Alliance Boots GmbH - Strategic Analysis Review	July 2009	£83	14.5 %
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production A Study of Biotherapeutic Developers and Contract Manufacturing Organizations, 2007	April 2008	£1050	14.5 %
King Pharmaceuticals Inc.: PharmaVitae Profile	March 2009	£1990	14.35 %
Indian Generics, 2008-2012 A Growing Threat to Westernised Markets	January 2008	£1600	14.35 %
The increasing importance of CRM in the pharma industry (Technology Focus)	August 2007	£660	14.35 %
Effective Licensing & Commercialisation of Drug Delivery Systems 2006	July 2006	£2500	14.35 %
Alcon Inc.: PharmaVitae Profile	March 2009	£1990	14.35 %
China Diabetes Drug Market Report The Chinese Hospital Cancer Drug Utilization	January 2009	£5285	14.35 %
China Allergy Drug Market Report The Chinese Allergy Cancer Drug Utilization	March 2009	£2970	14.35 %
Smoking Cessation Aids in Taiwan	December 2005	£450	14.35 %
Biogen Idec Pipeline Products Performance Potential	March 2008	£595	14.35 %
Wound Treatments in Argentina	August 2007	£450	14.35 %
Croatia Pharmaceuticals and Healthcare Report Q1 2010	November 2009	£250	14.35 %
Digestive Remedies in Thailand	July 2008	£450	14.35 %
The Future for Skincare in OTC Self-medication in Europe 2006 edition	June 2006	£1995	14.35 %
Canadian Pharmaceutical Market Outlook to 2013 olicy environment, market structure, pipeline analysis, growth opportunities	March 2009	£2025	14.35 %
CNS Therapeutics A World Market Review	November 2009	£1980	14.35 %
Digestive Remedies in Indonesia	April 2009	£560	14.35 %
Cough, Cold and Allergy (Hay Fever) Remedies in Japan	September 2007	£450	14.35 %
Leading Pharmaceutical Companies Financial Analyses	September 2009	£1220	14.35 %
Cough, Cold and Allergy (Hay Fever) Remedies in Mexico	February 2008	£450	14.35 %
Analgesics in Thailand	July 2008	£450	14.35 %
Vitamins and Dietary Supplements in Thailand	July 2008	£450	14.35 %
Analgesics in Indonesia	April 2009	£560	14.35 %
Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong	October 2007	£450	14.35 %
Venezuela Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	14 %
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023	May 2008	£1499	14 %
World Gastrointestinal Disorders Market 2008-2023	October 2008	£1499	14 %
Cough, Cold and Allergy (Hay Fever) Remedies in Indonesia	April 2009	£560	14 %
China Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	14 %
Vitamins and Dietary Supplements in Indonesia	April 2009	£560	14 %
Genentech Inc.: PharmaVitae Profile	March 2009	£1990	14 %
Somaxon Pharmaceuticals Inc Premium Company Profile	March 2008	£175	14 %
H Lundbeck A/S - SWOT Analysis	June 2008	£44	14 %
Daiichi Sankyo Co., Ltd: PharmaVitae Profile	February 2009	£1990	14 %
NRT Smoking Cessation Aids in Thailand	July 2008	£450	14 %
Insulin Competitor Analysis	October 2008	£360	14 %
PSS World Medical, Inc. SWOT Analysis	November 2008	£44	14 %
When Patients Become Plaintiffs A Primer on Drug and Medical Device Liability	January 2006	£1095	14 %
Medicated Skin Care in Indonesia	April 2009	£560	14 %
China Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	14 %
Switzerland Pharmaceuticals and Healthcare Report Q4 2008	October 2008	£425	14 %
Greece Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	14 %
OTC Distribution in Europe - 2007 Exploring New Frontiers	June 2007	£1595	14 %
Vitamins and Dietary Supplements in India	August 2006	£450	14 %
Consolidation in the Generic Pharmaceutical Industry An evolving landscape	October 2007	£1250	14 %
Sciele Pharma Inc Premium Company Profile	December 2007	£175	14 %
China Sky One Medical, Inc. - Financial and Strategic Analysis Review	June 2009	£83	14 %
Alpha Pro Tech, Ltd. - Financial and Strategic Analysis Review	June 2009	£83	14 %
Cardiovascular Generic Drugs Prospects and Opportunities to 2012	December 2007	£995	14 %
Celgene Corporation: PharmaVitae Profile Healthcare	March 2009	£1990	14 %
AAIPharma Inc. - Strategic Analysis Review	July 2009	£83	14 %
Eye Care in India	February 2008	£450	14 %
Kazakhstan Pharmaceuticals and Healthcare Report Q2 2009	May 2009	£250	14 %
Solvay SA - Financial and Strategic Analysis Review	April 2009	£83	14 %
Sgx Pharmaceuticals Inc Premium Company Profile	December 2007	£175	14 %
Singapore Pharmaceuticals & Healthcare	January 2007	£395	14 %
Takeda Pharmaceutical Co. Ltd: PharmaVitae Profile	February 2009	£1990	14 %
MGI Pharma Inc - SWOT Analysis	November 2007	£42	14 %
Hikma Pharmaceuticals - Financial and Strategic Analysis Review	June 2009	£83	14 %
Mylan Inc. - Financial and Strategic Analysis Review	June 2009	£83	14 %
Generic Series: An Introduction to the Canadian Generics Market Key trends and leading companies shaping the market	June 2007	£1325	14 %
OTC market in Poland 2007 Development forecasts 2007-2009	June 2007	£1480	14 %
QLT Inc: Premium Company Profile Premium Company Profile	January 2008	£175	14 %
Alliance Boots Plc - SWOT Analysis	January 2009	£44	14 %
State of the Clinical Trials Industry 2007	May 2007	£395	13.65 %
Healthcare and Pharmaceuticals in Latin America A guide to the markets and regulations	May 2005	£525	13.65 %
OTC Healthcare in Cameroon	June 2008	£1200	13.65 %
Wyeth: PharmaVitae Profile PharmaVitae Profile	March 2009	£1990	13.65 %
Sepracor Inc.: PharmaVitae Profile	March 2009	£1990	13.65 %
United States Woundcare Management Medical Equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	April 2008	£1980	13.65 %
Alcon Pipeline,Products,Performance,Potential	December 2008	£595	13.65 %
NRT Smoking Cessation Aids in India	February 2008	£450	13.65 %
Biogen Idec: Pipeline - Products - Performance - Potential	January 2010	£595	13.65 %
Genzyme Corporation: PharmaVitae Profile	March 2009	£1990	13.65 %
Emerging Pharmaceutical Markets Growth Opportunities, Changing Healthcare Dynamics And Regulatory Trends	September 2007	£1495	13.65 %
OTC Healthcare - Serbia	April 2009	£750	13.65 %
Medicated Skin Care in Thailand	July 2008	£450	13.65 %
Argentina Wound Care Management Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1980	13.65 %
Medicated Skin Care in Taiwan	December 2005	£450	13.65 %
Cough, Cold and Allergy (Hayfever) Remedies in Taiwan	December 2005	£450	13.65 %
Mexico Wound Care Management Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1980	13.65 %
Analgesics in India	August 2006	£450	13.65 %
Schering-Plough Corporation PharmaVitae Profile	July 2008	£1980	13.65 %
Analgesics in Denmark	November 2007	£450	13.65 %
Wound Treatments in India	August 2006	£450	13.65 %
Daiichi Sankyo, Ltd. SWOT Analysis	November 2008	£44	13.5 %
Croatia Pharmaceuticals and Healthcare Report Q4 2008	October 2008	£425	13.5 %
Eli Lilly and Company SWOT Analysis	November 2008	£44	13.5 %
Innovations In Epigenetics Advances in Technologies, Diagnostics & Therapeutics	November 2009	£3835	13.5 %
PSS World Medical, Inc. - SWOT Analysis	November 2008	£44	13.5 %
Novo Nordisk Pharmaceutical Company Intelligence Report Prospects to 2010	May 2007	£595	13.5 %
Antipsychotics Market Insight & Analysis 2008	February 2008	£1499	13.5 %
The Asian Cardiovascular Market Outlook to 2014 Regional and therapeutic analysis, pipeline impact and growth opportunities	March 2009	£2025	13.5 %
The Antipsychotics Market Insight & Analysis 2008	February 2008	£1499	13.5 %
Endometriosis Drug Pipeline Analysis and Market Forecasts to 2016	February 2010	£1320	13.5 %
Purdue Pharma L.P. - Strategic Analysis Review	March 2009	£83	13.5 %
Daiichi Sankyo, Ltd. - SWOT Analysis	November 2008	£44	13.5 %
Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	13.5 %
Shire Plc - Financial and Strategic Analysis Review	April 2009	£83	13.5 %
Pfizer Inc. - Financial and Strategic Analysis Review	April 2009	£83	13.5 %
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market	April 2008	£5285	13.5 %
Eli Lilly and Company - Financial and Strategic Analysis Review	June 2009	£83	13.5 %
Eli Lilly and Company - SWOT Analysis	November 2008	£44	13.5 %
Barrier Therapeutics, Inc. - Strategic Analysis Review	March 2009	£83	13.5 %
Greece Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	13.3 %
Gas Chromatography Systems World Review	November 2009	£1980	13.3 %
Japan Generics Market Intelligence Report	October 2006	£295	13.3 %
Pharmaceutical Outsourcing Opportunities Post-Launch Contract Manufacturing and Contract Sales and Marketing, 3rd Edition	January 2009	£2310	13.3 %
Israel Wound Care Management Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1980	13.3 %
The Global Anti-Infectives Market Outlook to 2011	June 2007	£1495	13.3 %
Shire plc: PharmaVitae Profile	November 2008	£1990	13.3 %
Stakeholder Opinions Melanoma Lucrative commercial opportunities persist	October 2007	£1980	13.3 %
Bristol-Myers Squibb Co.: PharmaVitae Profile	September 2009	£3765	13.3 %
World Contract Research and Manufacturing Market, 2006-2011, The Trends in Outsourcing	August 2006	£1499	13.3 %
OTC Healthcare - Kazakhstan	April 2009	£750	13.3 %
Analgesics in Finland	October 2007	£450	13.3 %
Outlook 2007	January 2006	£895	13.3 %
Republic of Korea Wound Care Management Medical Equipment Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	May 2008	£1980	13.3 %
Mexico Wound Care Management Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	May 2008	£1980	13.3 %
Serbia Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	13.3 %
Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006	March 2006	£1320	13.3 %
The Dermatology Market Outlook to 2011	March 2007	£1495	13.3 %
Baxter International Medical Device Company Intelligence Report	March 2009	£295	13.3 %
Merck & Co. Inc: PharmaVitae Profile	July 2009	£3765	13.3 %
South Africa Wound Care Management Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1980	13.3 %
Women's Health Market Outlook to 2011	May 2007	£1495	13.3 %
Eye Care in Norway	October 2007	£450	13.3 %
Medicated Skin Care in India	February 2008	£450	13.3 %
Cough, Cold and Allergy (Hay Fever) Remedies in India	February 2008	£450	13.3 %
Wyeth PharmaVitae Profile	July 2008	£1980	13.3 %
Bayer Schering Pharma Ag PharmaVitae Profile	July 2008	£1980	13.3 %
Indian Pharmaceutical Industry, The:	March 2005	£3335	13.3 %
Nycomed Pipeline Products Performance Potential	October 2007	£595	13.3 %
Shire plc SWOT Analysis	November 2008	£44	13 %
Santarus, Inc. - SWOT Analysis SWOT Analysis	September 2008	£44	13 %
Tercica Inc Premium Company Profile	December 2007	£175	13 %
Novo Nordisk AS - Financial and Strategic Analysis Review	April 2009	£83	13 %
Suzuken Co, Ltd. - SWOT Analysis	August 2009	£83	13 %
Novo Nordisk A/S - Financial and Strategic Analysis Review	June 2009	£83	13 %
Savient Pharmaceuticals Inc - SWOT Analysis	September 2008	£44	13 %
Slentrol Case Study: Using Integrated PR Tactics to Support a Product Launch	October 2008	£665	13 %
European Animal Health Regulations (2 volumes)	January 2007	£895	13 %
Cardinal Health, Inc. SWOT Analysis	November 2008	£44	13 %
Novartis AG - SWOT Analysis	November 2008	£44	13 %
Barr Pharmaceuticals Generics Company Intelligence Report	June 2008	£195	13 %
Cardinal Health, Inc. - SWOT Analysis SWOT Analysis	November 2008	£44	13 %
EpiCept Corporation - Financial and Strategic Analysis Review	June 2009	£83	13 %
Russia Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	13 %
Boiron SA - SWOT Analysis	September 2008	£44	13 %
Egypt Pharmaceuticals & Healthcare	May 2009	£250	13 %
Novartis AG SWOT Analysis	November 2008	£44	13 %
Cypress Bioscience, Inc - Financial and Strategic Analysis Review	June 2009	£83	13 %
Malaysia Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	12.95 %
Mobile and Wireless Sales Force Strategies	April 2006	£75	12.95 %
India Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	12.95 %
Obesity, Weight Loss and Diet Management Markets Pharmaceutical, Surgical and Dietary Approaches	December 2009	£2310	12.95 %
Canada Wound Care Management Medical Equipment Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	May 2008	£1980	12.95 %
Prescribing Pharmacists A Decision Maker Emerges	September 2007	£1650	12.95 %
Shionogi: Pipeline - Products - Performance - Potential	March 2008	£595	12.95 %
Biologic drugs to drive pharmaceutical market growth	October 2006	£590	12.95 %
All Change in the US Pharma Market?	June 2008	£995	12.95 %
The Pharmaceutical Market Chile	May 2008	£595	12.95 %
Saudi Arabian Healthcare Market Forecast to 2012	August 2009	£530	12.95 %
Japan Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	12.95 %
China Wound Care Management Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	May 2008	£1980	12.95 %
Radio Frequency Identification (Rfid) in Pharmaceuticals Supply Chain Security Concerns Provide Impetus for Rfid Adoption	February 2010	£2310	12.95 %
Eye Care in Russia	November 2007	£450	12.95 %
Asia Pacific Pharma Sector Analysis	November 2009	£795	12.95 %
Bristol-Myers Squibb Pipeline, Products, Performance, Potential	February 2008	£595	12.95 %
Gilead Sciences Performance, Products, Pipeline and Potential	February 2008	£595	12.95 %
Republic of Korea Wound Care Management Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1980	12.95 %
Commercial Insight: Depression Atypical lifecycle management strategy rejuvenates depression market	June 2007	£5020	12.95 %
CHINA: Major report covers impact of health reforms on China's Pharmaceutical Market Impact of China's Health Reforms	October 2009	£130	12.6 %
Specialty Pharma Market Outlook, The Key players, new company growth models and emerging opportunities	October 2006	£1495	12.6 %
Commercial Insight: Antidiabetics Patent expiries and cost containment initiatives balanced by pipeline products	August 2007	£5290	12.6 %
Chiral Technology International Technology & Market Trends	November 2009	£1980	12.6 %
OTC Healthcare in Azerbaijan	March 2009	£750	12.6 %
Online Marketing and eDetailing Europe	July 2007	£75	12.6 %
Japan Wound Care Management Medical Equipment Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	May 2008	£1980	12.6 %
The Pharmaceutical Company Outlook To 2012 Strategic Analysis Of The Sales Outlook For Big Pharma, Mid Pharma, Japan Pharma And Biotech	December 2007	£2510	12.6 %
Australia Wound Care Management Medical Equipment Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	May 2008	£1980	12.6 %
Russia Generics Market Intelligence Report	April 2006	£295	12.6 %
Reaching Doctors and Patients Through New Digital Media	January 2008	£1320	12.6 %
Eisai Pipeline - Products - Performance - Potential	June 2008	£595	12.6 %
Mid Pharma Sector In-licensing and other externalization strategies	June 2006	£2875	12.6 %
Rx market in Poland 2006 Development forecasts 2006-2008	November 2006	£1390	12.6 %
Contract Manufacturing Strategies Market developments, technology transfer and key success factors	May 2008	£1535	12.6 %
Ophthalmic Pharmaceutical Drugs A Global Market Perspective	November 2009	£1980	12.6 %
Teva Pharmaceutical Industries Generics Company Intelligence Report	June 2008	£195	12.6 %
The Global OTC Pharmaceutical Market 2009-2024	May 2009	£1499	12.6 %
Forecast Insight: Antidiabetics - Switching to new molecule antidiabetics drives market growth	August 2008	£5020	12.6 %
Tercica, Inc. - SWOT Analysis	January 2009	£44	12.5 %
The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide	September 2009	£235	12.5 %
Martek Biosciences Corp: Premium Company Profile Premium Company Profile	January 2008	£175	12.5 %
Specialty Chemicals Source Book Fourth Edition	January 2009	£245	12.5 %
Brazil Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	12.5 %
Switzerland Pharmaceuticals and Healthcare Report Q1 2009	January 2009	£250	12.5 %
Abbott Medical Device Company Intelligence Report	October 2009	£295	12.5 %
The Outlook for Pharmaceuticals in Latin America	March 2007	£1995	12.5 %
AXM Pharma, Inc. - Financial and Strategic Analysis Review	April 2009	£83	12.5 %
Depomed, Inc. - Financial and Strategic Analysis Review	June 2009	£83	12.5 %
AtheroGenics, Inc. - Financial and Strategic Analysis Review	April 2009	£83	12.5 %
Javelin Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	12.5 %
The Dermatology Market Outlook to 2013 Competitive Landscape, Pipeline Analysis and Growth Opportunities	October 2008	£2025	12.5 %
Auriga Laboratories Inc. - Financial and Strategic Analysis Review	April 2009	£83	12.5 %
IMS Health Incorporated - Financial and Strategic Analysis Review	June 2009	£83	12.5 %
Dainippon Sumitomo Pharma Co., Ltd. - Financial and Strategic Analysis Review	July 2009	£83	12.5 %
Regenerative Medicines: Bone and Joint Applications	October 2009	£3205	12.5 %
Argentina Wound Care Management Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	May 2008	£1980	12.25 %
World Respiratory Disorders Market 2009-2024	June 2009	£1499	12.25 %
Ono: Pipeline, Products, Performance, Potential	November 2007	£595	12.25 %
Germany Wound Care Management Medical Equipment Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	May 2008	£1980	12.25 %
Amgen Prospects to 2010	February 2009	£595	12.25 %
Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007, The	January 2007	£1485	12.25 %
Serono Prospects to 2010 Prospects to 2010	November 2006	£795	12.25 %
Cardiovascular Pharmaceutical Market Trends, 2007 to 2010 Key market forecasts and growth opportunities	August 2007	£895	12.25 %
Wound Treatment in Belgium	November 2005	£450	12.25 %
CNS Market Trends, 2007 to 2010 Key Market Forecasts and Growth Opportunities	June 2007	£995	12.25 %
Astellas Pharma: Pipeline, Products, Performance, Potential	November 2007	£595	12.25 %
MarketWatch: Health Roundup	November 2008	£140	12.25 %
Czech Republic Generics Market Intelligence Report	January 2006	£295	12.25 %
Contract Research and Manufacturing Services India (CRAMS)	March 2008	£600	12.25 %
Tanabe Prospects to 2010 Pipeline, Products,Performance,Potential	September 2007	£595	12.25 %
Israel Wound Care Management Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	May 2008	£1980	12.25 %
Merck KGaA: PharmaVitae Profile	March 2009	£1990	12.25 %
Mitsubishi Pharma: Pipeline, Products, Performance, Potential	October 2007	£595	12.25 %
Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations (3rd Edition)	September 2008	£899	12.25 %
Warner Chilcott Limited - Financial and Strategic Analysis Review	June 2009	£83	12 %
McKesson Corporation - Financial and Strategic Analysis Review	June 2009	£83	12 %
Oramed Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	April 2009	£83	12 %
Global R&D Spend 2002-2004	October 2005	£470	12 %
Therapeutics for Inflammatory Diseases Current Challenges and Future Market	March 2006	£2885	12 %
Belgium Pharmaceuticals and Healthcare Report Q1 2010	November 2009	£250	12 %
Oncology Market Leaders Analyses and Outlook, Market Report 2008 - 2023	October 2008	£1499	12 %
Gedeon Richter Plc. - Financial and Strategic Analysis Review	June 2009	£83	12 %
Echo Therapeutics, Inc. - Financial and Strategic Analysis Review	June 2009	£83	12 %
Consort Medical plc - Financial and Strategic Analysis Review	June 2009	£83	12 %
Acura Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	12 %
Eurand N.V. - Financial and Strategic Analysis Review	June 2009	£83	12 %
Blockbuster Pharmaceutical Launches Establishing Market Leadership	May 2006	£2175	12 %
Neurocrine Biosciences, Inc. - Financial and Strategic Analysis Review	June 2009	£83	12 %
Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies More drugs on the market, more targets in the pipeline	October 2006	£5285	12 %
Merck & Co and Schering-Plough - a marriage of convenience?	August 2009	£295	12 %
Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)	January 2009	£2310	12 %
Cobalis Corporation - Financial and Strategic Analysis Review	April 2009	£83	12 %
ART Advanced Research Technologies, Inc. - Financial and Strategic Analysis Review	June 2009	£83	12 %
Sanofi-Aventis - Financial and Strategic Analysis Review	June 2009	£83	12 %
Celesio AG - Financial and Strategic Analysis Review	June 2009	£83	12 %
BMS & Medarex: a valuable partnership?	August 2009	£175	11.9 %
The Cardiovascular Disorders Market Outlook to 2012	February 2008	£1995	11.9 %
Pfizer Prospects to 2010 Pipeline, Products,Performance,Potential	September 2007	£595	11.9 %
Cancer Therapies: Technologies and Global Markets	January 2008	£3205	11.9 %
Freeze Drying Equipment A Global Market Perspective	November 2009	£1980	11.9 %
The Pharmaceutical Market Spain	May 2008	£595	11.9 %
Laboratory Balances & Scales World Review	November 2009	£1980	11.9 %
Roche: Prospects to 2010 Pipeline, Products,Performance,Potential	September 2007	£595	11.9 %
Cardiac Toxicity	March 2008	£1495	11.9 %
Serbia Pharmaceuticals and Healthcare Report Q1 2009	January 2009	£250	11.9 %
Commercial Insight: Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets	February 2009	£5285	11.9 %
Animal Pharm's Top 20 2006 edition	January 2006	£795	11.9 %
eSampling Strategies Using Internet Technologies to Increase Impact at the Point of Care	October 2006	£1325	11.9 %
Emerging Pharmaceutical Markets Globally	April 2008	£990	11.9 %
Pharmaceutical Product Approval Trends, 2007 Key Market Benchmarks And Strategic Insights	December 2007	£995	11.9 %
Health and Wellness Healthcare Products in South Korea	November 2006	£650	11.9 %
Drug Safety for Marketed Drugs	April 2006	£75	11.9 %
Brazil Wound Care Management Medical Equipment Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies	May 2008	£1980	11.9 %
Pharmaceutical Markets in India	April 2004	£855	11.9 %
Chinese Pharmaceutical Industry Strategies, Trends and Opportunities	August 2005	£3330	11.9 %
Pharmaceutical Markets in Brazil, Russia, India and China (Bric Nations)	July 2008	£1165	11.9 %
Bringing Drugs to Market The role of CRM in improving sales & marketing (Review Report)	August 2007	£660	11.55 %
Laboratory Glassware and Plasticware Global Market Opportunities	November 2009	£1980	11.55 %
Monoclonal Antibodies Report Part II Companies - Holding Mabs In Portfolio Promises Protection Against The Looming 2011-12 Patent Cliff	September 2007	£2510	11.55 %
Fresenius Medical Device Company Intelligence Report	March 2009	£295	11.55 %
The Future of the Pharmaceutical Packaging Industry Emerging Economies Poised to Capitalize on Increasing Demand	December 2009	£2310	11.55 %
Orphan Drugs in Asia Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2009	January 2009	£1020	11.55 %
Digestive Remedies in Australia	July 2008	£450	11.55 %
Global Cardiovascular Drugs Market 2009-2024	June 2009	£1499	11.55 %
OTC Healthcare in Uruguay	July 2008	£1200	11.55 %
United States Pharmaceuticals and Healthcare Report Q3 2006	July 2006	£395	11.55 %
Monoclonal Antibodies Report	June 2008	£2510	11.55 %
Analgesics in Australia	July 2008	£450	11.55 %
Drug Development Opportunities In China Regulation, Key Players And Initiatives For Domestic And International Markets	September 2007	£1495	11.55 %
Mitsubishi Tanabe Pharma Corporation Pharmavitae Profile	December 2007	£1980	11.55 %
Wound Treatments in Australia	July 2008	£450	11.55 %
Animal Pharm's Top Tier Companies 2007 edition	January 2007	£895	11.55 %
Pharma Marketing ROI	January 2007	£75	11.55 %
Achieving success in the Developing Asian Pharmaceutical Sector 2007-2011	November 2006	£1999	11.55 %
AstraZeneca Pharmaceuticals, Company Profile and Healthcare	June 2008	£595	11.55 %
Vitamins and Dietary Supplements in Australia	July 2008	£450	11.55 %
Mitsubishi: PharmaVitae Profile 2005	March 2006	£2175	11.55 %
The CNS Market Outlook to 2013 Competitive landscape, pipeline analysis and growth opportunities	September 2008	£1995	11.5 %
AMD Market Outlook to 2012	March 2007	£1299	11.5 %
aaiPharma Inc - SWOT Analysis	July 2008	£44	11.5 %
Biomarkers in Drug Discovery Optimizing Drug Discovery Timeline and Costs	February 2010	£2310	11.5 %
Smiths Medical Medical Device Company Intelligence Report	February 2009	£295	11.5 %
Obesity Drug Discoveries: what the future holds	August 2007	£1425	11.5 %
United Drug plc - Financial and Strategic Analysis Review	June 2009	£83	11.5 %
Sepracor Inc. - Financial and Strategic Analysis Review	June 2009	£83	11.5 %
Biochips Industry forecasts for 2012 & 2017	October 2008	£3040	11.5 %
STADA Arzneimittel AG - Financial and Strategic Analysis Review	April 2009	£83	11.5 %
Leading Drug Delivery Companies and Technologies Competitive landscape, company profiles and technological developments	June 2008	£1320	11.5 %
Solvay Group - SWOT Analysis	February 2008	£42	11.5 %
Small & Specialty Drug Branding Tapping Niche Market Potential	May 2006	£2175	11.5 %
Mitsubishi Tanabe Pharma Corporation - Financial and Strategic Analysis Review	July 2009	£83	11.5 %
Eisai Co., Ltd. - Financial and Strategic Analysis Review	July 2009	£83	11.5 %
GlaxoSmithKline plc - Financial and Strategic Analysis Review	July 2009	£83	11.5 %
Warnex Inc. - Financial and Strategic Analysis Review	June 2009	£83	11.5 %
5-HT7 antagonists Novel molecules for the unmet migraine prophylaxis market	March 2003	£330	11.5 %
DURECT Corporation - Financial and Strategic Analysis Review	June 2009	£83	11.5 %
Japan Pharmaceuticals and Healthcare Report Q1 2009	March 2009	£250	11.2 %
How to React to Parallel Trade	January 2007	£1095	11.2 %
Colorectal Cancer: Pipeline/Commercial Insight Shaping the future dynamics of colorectal cancer management	October 2006	£5285	11.2 %
Monoclonal Antibodies in Cancer Therapy 2009-2024	May 2009	£1499	11.2 %
Understanding Chiral Technologies Chiral Technology Revenues Soar to $16.03 Billion	November 2008	£395	11.2 %
The China Pharmaceutical Market: A Strategic Opportunity Analysis	January 2007	£840	11.2 %
eHealth Solutions for Pharma Strategies for salesforces, marketing, patient compliance and clinical trials	March 2007	£1495	11.2 %
MarketWatch: Health Round-up	October 2008	£140	11.2 %
NRT Smoking Cessation Aids in Australia	July 2008	£450	11.2 %
Emerging Pharmaceutical Markets Argentina and Mexico	March 2008	£2510	11.2 %
Commercial Insight: Antihormonal Therapy Cancer Brands Careful Lifecycle Management Needed to Preserve Brand Dominance	August 2008	£5020	11.2 %
India Pharmaceuticals and Healthcare Report Q1 2009	February 2009	£250	11.2 %
China Vaccine Market Report 2007-2009	July 2008	£890	11.2 %
Hplc Systems & Accessories A World Market Review	November 2009	£1980	11.2 %
Pipettes & Pipettors A Global Market Perspective	November 2009	£1980	11.2 %
Astellas Pharma Inc. - Financial and Strategic Analysis Review	July 2009	£83	11 %
Kinase Therapeutics Pipeline Assessment and Commercial Prospects	January 2010	£2995	11 %
Leading Indicators in Life Science IT Spending Survey - 1Q06	March 2006	£2580	11 %
Premium Company Profile: Invitrogen Corporation	November 2007	£175	11 %
How Drugs Are Developed 3rd Edition	January 2007	£1095	11 %
Multiple Sclerosis World Market Outlook to 2011	June 2007	£1980	11 %
Dynamic Antibody Industry	August 2005	£2885	11 %
Spain Pharmaceuticals & Healthcare	July 2006	£395	11 %
Purdue Pharma - SWOT Analysis	October 2008	£44	11 %
Anti-Infectives World Market, 2nd. Ed., Vol. I	March 2007	£1980	11 %
Next Generation Protein Engineering and Drug Design Strategies to boost efficacy and improve drug delivery	February 2007	£1495	11 %
Menarini Group - SWOT Analysis	June 2008	£44	11 %
Vietnam Pharmaceuticals & Healthcare	December 2006	£395	11 %
World Neurodegenerative Diseases Market 2009-2024	September 2009	£1499	11 %
US Oncology, Inc. - SWOT Analysis - SWOT Analysis	October 2008	£44	11 %
Apotex, Inc. - SWOT Analysis	October 2008	£44	11 %
Infusion Pumps Worldwide 2009	April 2009	£2310	11 %
Monoclonal Antibodies Report Part I	June 2007	£2510	10.85 %
Indian Bulk Drug Industry Insight 2007	May 2007	£400	10.85 %
Daiichi Sankyo Co., Ltd Pharmavitae Profile	December 2007	£1990	10.85 %
OTC Distribution in Europe - 2007 edition Exploring New Frontiers	June 2007	£1595	10.85 %
Japanese Pharmaceutical Market 2008-2023, the	October 2008	£1499	10.85 %
United States Dental Devices Medical Equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Dental Equipment, Dental Supplies, Orthodontic Products, Dental X-Ray Equipment, Devices and Supplies	April 2008	£1980	10.85 %
RFID in Pharmaceutical Manufacturing Cost Saving Strategies for Pharmaceutical Companies and Opportunities for Technology Companies	March 2008	£1320	10.85 %
Biotech 2010	June 2006	£2885	10.85 %
Commercial Insight: Antihypertensives New challenges for a maturing market	September 2006	£5285	10.85 %
Global Antivirals Market Analysis & Forecasts 2008-2023	September 2008	£1499	10.85 %
Reporting Adverse Events	September 2006	£75	10.85 %
Medicated Skin Care in Australia	July 2008	£450	10.85 %
OTC Healthcare in Slovenia	February 2009	£750	10.85 %
Forecast Insight: Dyslipidemia - Genericization and negative trial data drive market shrinking	August 2008	£5020	10.85 %
Partnering in the Global Generics Industry 2008: A guide to companies	July 2008	£595	10.85 %
Direct to Consumer (DTC) Advertising in Pharmaceuticals Current and Future Market Outlook, Regulatory Landscape and Case Studies	December 2009	£2310	10.85 %
Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics 2009-2023	January 2009	£1499	10.85 %
Omnicare, Inc - SWOT Analysis	August 2009	£83	10.5 %
Commercial Insight: Antidiabetics in Australia Reimbursement status shapes novel classes	October 2009	£3765	10.5 %
OTC market in Central and Eastern Europe 2009 Comparative analysis and development forecasts for 2009-2011	August 2009	£2240	10.5 %
Biotechnological Innovations In The Pharmaceutical Industry in Poland 2009 Development forecasts for biotechnology sector for 2009-2011	August 2009	£1790	10.5 %
Merck & Co., Inc. SWOT Analysis	November 2008	£44	10.5 %
Pharmaceutical Pricing and Distribution in Japan The keys to success in the world's second largest market	June 2008	£1450	10.5 %
China Anti-Cancer Drug Market Report The Chinese Hospital Cancer Drug Utilization	December 2008	£5285	10.5 %
Wound Care Products A World Market Analysis	November 2009	£1980	10.5 %
STERIS Corporation SWOT Analysis	November 2008	£44	10.5 %
The Pharma & Social Media Reports Covering branded sites, physician sites, patient communities	November 2009	£575	10.5 %
World Sleep Disorders Market Analysis 2009-2024	June 2009	£1499	10.5 %
The Global Pain Therapeutics Market Market Analysis, R&D Pipelines and Competitive Landscape	October 2007	£1980	10.5 %
CollaGenex Pharmaceuticals, Inc. - SWOT Analysis	March 2008	£42	10.5 %
Bayer Schering Pharma AG - SWOT Analysis	March 2008	£42	10.5 %
Johnson Matthey PLC - SWOT Analysis	February 2008	£42	10.5 %
Future Growth Opportunities in Generics The impact of consolidation on market and competitive dynamics	November 2006	£1495	10.5 %
Pfizer Inc - SWOT Analysis	March 2008	£42	10.5 %
Sanofi-aventis Pipeline, Products,Performance,Potential	September 2007	£249	10.5 %
Sepracor Inc. - SWOT Analysis	August 2009	£83	10.5 %
Les Laboratoires Servier - SWOT Analysis	June 2008	£44	10.5 %
Psychopharmacotherapy Market Insights Obstacles & Opportunities in Mood Disorders & Cognitive Impairment, 2005-2012	November 2005	£795	10.5 %
Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing Using Analytics and Metrics to Improve the Bottom Line	March 2007	£997	10.5 %
Prostate and Breast Cancer New Treatments & Developmental Progress	March 2007	£2115	10.5 %
King Pharmaceuticals, Inc - SWOT Analysis	August 2009	£83	10.5 %
Genta Incorporated - SWOT Analysis	December 2008	£44	10.5 %
AmerisourceBergen Corporation - SWOT Analysis	September 2008	£44	10.5 %
Merck & Co., Inc. - SWOT Analysis SWOT Analysis	January 2009	£44	10.5 %
OPG Groep - SWOT Analysis	October 2008	£44	10.5 %
Shire plc - SWOT Analysis SWOT Analysis	August 2009	£83	10.5 %
STERIS Corporation - SWOT Analysis	November 2008	£44	10.5 %
Pharmion Corporation - SWOT Analysis	July 2007	£42	10.5 %
Wyeth Prospects to 2010 Performance, Products, Pipeline and Potential	July 2007	£595	10.5 %
Isis Pharmaceuticals Inc Premium Company Profile	December 2007	£175	10.5 %
The Autoimmune Inflammatory Bowel Disease Market Outlook to 2012	February 2007	£1499	10.15 %
Strategic Management of Resources and Portfolios Structuring Risk to Maximize Opportunity in Pharmaceutical R&D	August 2008	£2475	10.15 %
Parallel Trade in Europe and the US The challenges facing pharma	April 2006	£2435	10.15 %
Prospects for Legalizing Drug (Re-)Importation to the United States	June 2009	£970	10.15 %
Diabetes Therapies & Diagnostics: Global Markets	January 2008	£3205	10.15 %
Astellas: PharmaVitae Profile	February 2007	£680	10.15 %
Emerging Generic Drug Markets in Europe	December 2007	£795	10.15 %
Advanced Drug Delivery Systems: New Developments, New Technologies	August 2009	£3205	10.15 %
Pharmaceutical Wholesale and Distribution Industry Outlook & Analysis 2008, The	June 2008	£1499	10.15 %
Innovative And Targeted Cancer Therapies Key Technologies, New Applications And Leading Players	July 2007	£1495	10.15 %
Laparoscopic Devices Market Research Report Worldwide	June 2009	£1320	10.15 %
Syringes (Disposable and Reusable) Global Market Opportunities	November 2009	£1980	10.15 %
Marketing ROI for Pharma	January 2006	£75	10.15 %
Global Generics Guide Benchmarking the key players	April 2006	£2640	10.15 %
Merck KGaA - OTC Healthcare - World	January 2008	£195	10.15 %
Cancer Therapeutics Markets	May 2008	£2245	10.15 %
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs	May 2007	£995	10.15 %
Pharmaceuticals in China	February 2006	£3170	10.15 %
World Gastrointestinal Disorders Market 2006-2011; The	January 2006	£1799	10.15 %
Gamma/Scintillation Cameras Global Trends	November 2009	£1980	10.15 %
The Global Market for Pain Management Drugs and Devices	August 2009	£3205	10.15 %
Labopharm Inc Premium Company Profile	December 2007	£175	10 %
World Market for Addiction Disorders, 2009 - 2016 The Future Therapies for Substance Dependence and Impulse Control	October 2009	£1495	10 %
Axcan Pharma Inc. - Strategic Analysis Review	March 2009	£83	10 %
Vical Incorporated Premium Company Profile	December 2007	£175	10 %
Nastech Pharmaceutical Company Inc - SWOT Analysis SWOT Analysis	March 2009	£44	10 %
Turkey Pharmaceuticals & Healthcare	September 2006	£395	10 %
Autism - Drug Pipeline Analysis and Market Forecasts to 2016	February 2010	£1320	10 %
EMR 2010 Market Analysis, ARRA Incentives, Key Players, and Important Trends	December 2009	£2310	10 %
AlphaRx, Inc. - Strategic Analysis Review	March 2009	£83	10 %
Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution Issues, initiatives and insights for supply chain integrity	September 2009	£2535	10 %
Johnson & Johnson - SWOT Analysis	November 2008	£44	10 %
Biotech Holdings Ltd. - Strategic Analysis Review	March 2009	£83	10 %
Biosimilars Series: Forecast Analysis	June 2009	£7530	10 %
Bayer AG - SWOT Analysis	August 2008	£44	10 %
Ipsen - SWOT Analysis	July 2008	£44	10 %
CollaGenex Pharmaceuticals Inc - SWOT Analysis SWOT Analysis	April 2008	£44	10 %
GlaxoSmithKline Plc - SWOT Analysis	October 2008	£44	10 %
Premium Company Profile: Cubist Pharmaceuticals	August 2008	£175	10 %
ISTA Pharmaceuticals, Inc. - SWOT Analysis SWOT Analysis	March 2009	£44	10 %
Bristol-Myers Squibb Company - SWOT Analysis	May 2008	£44	10 %
AstraZeneca PLC - SWOT Analysis	October 2008	£44	10 %
Pharmaceutical Supply Chain Strategies Reassessing Product Distribution to Cut Costs and Improve Supply Chain Management	March 2008	£1320	10 %
Drug Repositioning A market analysis	March 2006	£1095	10 %
Anesthesia Drugs Worldwide Markets	July 2007	£1980	10 %
Angiotech Pharmaceuticals, Inc. - SWOT Analysis	September 2008	£44	10 %
Barr Pharmaceuticals - SWOT Analysis	October 2008	£44	10 %
Gedeon Richter Ltd - SWOT Analysis	December 2008	£44	10 %
Wuxi Pharmatech (Cayman) Inc. - SWOT Analysis	August 2009	£83	10 %
Novo Nordisk A/S - SWOT Analysis	June 2008	£44	10 %
Schering AG - SWOT Analysis	October 2008	£44	10 %
Biologic Imaging Reagents Technologies and Global Markets	December 2008	£3205	10 %
Apotex, Inc. - Strategic Analysis Review	June 2009	£83	10 %
Millennium Pharmaceuticals, Inc. - SWOT Analysis	November 2008	£44	10 %
Merck KGaA - SWOT Analysis	March 2009	£44	10 %
Millennium Pharmaceuticals SWOT Analysis	November 2008	£44	10 %
The Top 100 In Vitro Diagnostics Manufacturing Companies In Europe (2nd ed.)	April 2004	£625	10 %
Johnson & Johnson SWOT Analysis	November 2008	£44	10 %
Premium Company Profile Idenix Pharmaceuticals, Inc.	October 2007	£175	9.8 %
Otsuka Prospects to 2010	August 2007	£249	9.8 %
PharmaHandbook - Volume One - Developed Markets Sixth Edition (2009)	June 2009	£330	9.8 %
Health and Wellness Healthcare Products in Finland	December 2006	£650	9.8 %
Antibiotics Global Trends	November 2009	£1980	9.8 %
Pediatric Drug Delivery Technology and Product Opportunities	February 2009	£1715	9.8 %
Japanese Pharmaceutical Market, 2006-2011	January 2006	£1499	9.8 %
Forecast Insight: Opioids - Saturation limits the commercial potential of individual brands Healthcare	March 2009	£5285	9.8 %
Top 10 Generic Pharmaceutical Companies, The Positioning, Performance and SWOT Analyses	July 2008	£1995	9.8 %
Cancer Market Trends 2008 - 2012 Key market forecasts and growth opportunities	January 2009	£1100	9.8 %
World Pharmaceutical Packaging Forecasts For 2011 & 2016 For 18 Countries	July 2007	£3830	9.8 %
World Generics Market, 2008-2013	November 2008	£1499	9.8 %
Emerging Markets Series: The Pharmaceutical Market of South Korea	October 2008	£2640	9.8 %
The Licensing Agreement in Pharmaceutical Business Development 3rd edition	July 2007	£450	9.8 %
Licensing Agreement in Pharmaceutical Business Development, The 3rd Edition	July 2007	£700	9.8 %
Cytogen Corporation - SWOT Analysis SWOT Analysis	April 2008	£44	9.5 %
CSL Ltd - Financial and Strategic Analysis Review	April 2009	£83	9.5 %
Global Drug Manufacturing Industry Outlook to 2010: Buyer Spend and Procurement Strategies and the Impact of Recession and Recovery	July 2009	£1320	9.5 %
Invitrogen Corporation SWOT Analysis	November 2008	£44	9.5 %
DepoMed Inc - SWOT Analysis	December 2008	£44	9.5 %
ConvaTec Medical Device Company Intelligence Report	October 2008	£395	9.5 %
Bioxel Pharma Inc. - Financial and Strategic Analysis Review	April 2009	£83	9.5 %
Schwarz Pharma AG - SWOT Analysis	February 2008	£44	9.5 %
ISTA Pharmaceuticals, Inc. - Strategic Analysis Review	March 2009	£83	9.5 %
Les Laboratoires Servier - Strategic Analysis Review	June 2009	£83	9.5 %
Chr. Hansen Holding AS - Strategic Analysis Review	March 2009	£83	9.5 %
APP Pharmaceuticals, Inc. - Strategic Analysis Review	June 2009	£83	9.5 %
The Global Antibacterials Market R&D Pipelines, Market Analysis and Competitive Landscape	August 2007	£820	9.5 %
MGI Pharma Inc - Strategic Analysis Review	March 2009	£83	9.5 %
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics	March 2010	£1495	9.5 %
Pulmonary Arterial Hypertension (PAH) Drug Pipeline Analysis and Market Forecasts to 2016	February 2010	£1320	9.5 %
Romania Pharmaceuticals and Healthcare Report Q3 2007	February 2009	£250	9.5 %
GSK's Cervarix A Future Blockbuster of 2007	March 2007	£1999	9.5 %
Invitrogen Corporation - SWOT Analysis	November 2008	£44	9.5 %
Drug Delivery Technology: Revolutionizing Cardiovascular Therapies	July 2007	£945	9.5 %
Anti-hypertension - Drug Pipeline Analysis and Market Forecasts to 2016	February 2010	£1320	9.5 %
200 China-based Best CROs and CMOs	March 2009	£990	9.5 %
Vectura Group Plc - SWOT Analysis	March 2009	£44	9.5 %
Oman Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	9.5 %
Atrial Fibrillation Drug Pipeline Analysis and Market Forecasts to 2016	February 2010	£1320	9.5 %
The Cardiovascular Market Outlook to 2013 Competitive Landscape, Global Market Analysis and Pipeline Analysis	January 2009	£2025	9.5 %
Stem Cell Research Market Trends, Investment Trends and Pipeline Analysis	February 2010	£2310	9.5 %
Chronic Obstructive Pulmonary Disease (COPD) Drug Pipeline Analysis and Market Forecasts to 2016	February 2010	£1320	9.5 %
Schering AG Prospects to 2010	November 2006	£895	9.45 %
Outsourcing Clinical Trials A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index	May 2007	£1980	9.45 %
Commercial Insight: Osteoarthritis Market sees steady growth	December 2006	£5285	9.45 %
Sterilization Technologies Advancing in the 21st Century	October 2005	£2885	9.45 %
Pfizer Market Outlook for a Global Leader, 2008-2013	August 2008	£1499	9.45 %
Electrophoresis Equipment & Supplies A World Market Review	November 2009	£1980	9.45 %
Nanotechnology in Health Care to 2009	May 2005	£2775	9.45 %
Pharmaceutical Regulatory Industry	January 2006	£2885	9.45 %
Anti-Obesity Treatments 2007-2012 - A blockbuster target market	July 2007	£1799	9.45 %
Coagulation Factors 2009 Target Pipeline and Corporate Benchmark Analysis	August 2009	£2195	9.45 %
Medicated Skin Care in Venezuela	February 2008	£450	9.45 %
France Generics Market Intelligence Report 9	February 2006	£295	9.45 %
Forecast Insight: HIV	June 2009	£10040	9.1 %
Therapeutic Monoclonal Antibodies Report 2008-2023	July 2008	£1499	9.1 %
Contract Pharma 2008-2023	August 2008	£1499	9.1 %
U.S. Market for Gastrointestinal Pharmaceuticals	September 2005	£2885	9.1 %
Valuing Pharmaceutical Innovation Pricing and Reimbursement for Innovative Therapies	July 2008	£1995	9.1 %
The World Market for Gynaecology 2007-2017	September 2007	£3200	9.1 %
Alcon, Inc. Healthcare - Medical Equipment SWOT Report	August 2008	£83	9.1 %
Licensing Strategies - Examining Todays Pharmaceutical Licensing Trends	November 2007	£5020	9.1 %
China Dermatosis Drug Market Report The Chinese Hospital Cancer Drug Utilization	February 2009	£5285	9.1 %
Innovations in The Management of Diabetes Next generation treatments and market dynamics	June 2008	£1995	9.1 %
Online Marketing and eDetailing	July 2006	£75	9.1 %
Global Markets for Antifungal Agents	March 2007	£3205	9.1 %
Generic League Market Analysis and Forecasts, 2007-2012, 2017 & 2022	February 2008	£1999	9.1 %
Innovations in Diagnostics	September 2006	£1495	9.1 %
Chinese Markets for Biotechnology	August 2006	£2640	9.1 %
Quintiles Transnational Corp. - Strategic Analysis Review	July 2009	£83	9 %
Rheumatoid Arthritis Market Competitive Landscape and Clinical Stage Analysis	May 2009	£985	9 %
Commercial Insight: Transplantation	June 2006	£5745	9 %
DUSA Pharmaceuticals, Inc - Financial and Strategic Analysis Review	June 2009	£83	9 %
Shionogi & Co., Ltd. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Arana Therapeutics Limited - Financial and Strategic Analysis Review	April 2009	£83	9 %
Mission Pharmacal Company - Strategic Analysis Review	June 2009	£83	9 %
Schwarz Pharma AG - Financial and Strategic Analysis Review	July 2009	£83	9 %
Cougar Biotechnology, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Breast Cancer - Therapeutic And Competitive Insights	February 2007	£1400	9 %
ViroPharma Incorporated - Financial and Strategic Analysis Review	June 2009	£83	9 %
Mitsubishi Tanabe Pharma Corporation - SWOT Analysis	September 2008	£44	9 %
Exelixis, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
EntreMed, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Agenix ltd. - Financial and Strategic Analysis Review	April 2009	£83	9 %
SuperGen, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Kinray, Inc. - Strategic Analysis Review	July 2009	£83	9 %
Genta Incorporated - Financial and Strategic Analysis Review	June 2009	£83	9 %
Salix Pharmaceuticals, Ltd. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Vectura Group plc - Financial and Strategic Analysis Review	June 2009	£83	9 %
Ranbaxy Laboratories Limited - SWOT Analysis	August 2009	£83	9 %
LifeCycle Pharma AS - Financial and Strategic Analysis Review	April 2009	£83	9 %
The New Trend of API Sourcing and Contract Manufacturing in China	February 2010	£1310	9 %
Aradigm Corporation - Financial and Strategic Analysis Review	June 2009	£83	9 %
MDRNA, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Meldex International PLC - Financial and Strategic Analysis Review	April 2009	£83	9 %
Monoclonal Antibody Therapeutics 2009-2024	August 2009	£1499	9 %
MediciNova, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
BioDelivery Sciences International, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Antibiotic Resistance and Antibiotic Technologies: Global Markets	November 2009	£3205	9 %
LifeCycle Pharma A/S - Financial and Strategic Analysis Review	June 2009	£83	9 %
Alexza Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
H Lundbeck AS - Financial and Strategic Analysis Review	June 2009	£83	9 %
SuperGen, Inc. - SWOT Analysis	December 2008	£44	9 %
VIVUS, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Savient Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
ALK-Abello AS - Financial and Strategic Analysis Review	June 2009	£83	9 %
Getinge Medical Device Company Intelligence Report	August 2006	£395	9 %
Cardinal Health, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Ipsen S.A. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Santarus, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Breast Cancer Therapeutic And Competitive Insights	February 2007	£1400	9 %
Omnicare, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
ISTA Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Labopharm Inc. - Financial and Strategic Analysis Review	June 2009	£83	9 %
Pricing & Reimbursement of Medicines in the United Kingdom Understanding the pharmaceutical market in the healthcare system	June 2005	£450	8.75 %
Commercial Insight: Migraine Opportunities Will Exist In The Wake Of Generic Attack	September 2007	£5020	8.75 %
Osteoporosis & Bone Metabolism Disorders Market 2008-2023	August 2008	£1499	8.75 %
Key Trends in Offshoring Pharmaceutical R&D Company strategies, emerging markets and impact on ROI	March 2009	£2025	8.75 %
The World Dermatological Market Outlook 2010-2024	November 2009	£1499	8.75 %
Generics in Japan	November 2009	£1825	8.75 %
Hematology Analyzer Instrumentation and Reagent Markets	July 2009	£2245	8.75 %
Next-Generation Nutraceuticals Food and pharma convergence in disease prevention and personalized nutrition	December 2006	£1495	8.75 %
Commercial Insight: Neuropathic Pain A Plethora of Patient Segmentation and Product Differentiation Opportunities	July 2006	£5575	8.75 %
United States Hospital Supplies Medical equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Hospital Disposables, Syringes, Needles, Sterilization, Disinfectant, Mobility Aid and Transportation Equipment, Appliances and Supplies	April 2008	£1980	8.75 %
Akzo Nobel Prospects to 2010	October 2006	£795	8.75 %
Pipeline Insight: Orphan Diseases in CNS - Part I: Huntington's Disease	November 2007	£2510	8.75 %
Osteoporosis Therapeutics A Global Market Perspective	November 2009	£1980	8.75 %
Retail Clinics and The in-Store Healthcare Market 2009 Bright Spot in The Current Economy?	March 2009	£2310	8.75 %
Commercial Insight: Epilepsy Companies Committed To The Cause Will Reap The Benefits	September 2007	£5020	8.75 %
The Pharmaceutical Market: India	February 2007	£595	8.75 %
Cadinal Health Medical Device Company Intelligence Report	April 2008	£395	8.75 %
United States Drug Delivery Devices Medical Equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Infusion Systems, Inhalation Systems and Needle Free Injections Medical Equipment and Supplies	April 2008	£1980	8.75 %
Monoclonal Antibodies 2007 Competitive Landscape & Pipeline Insight	January 2007	£1485	8.75 %
The Future of Targeted Therapeutics Key Technologies, New Therapy Area Applications and Leading Players	March 2008	£1995	8.75 %
Commercial Insight: Asthma & COPD Combination Products Still Have Blockbuster Potential	July 2007	£5020	8.75 %
Microplate Instrumentation & Supplies A Global Market Perspective	November 2009	£1980	8.75 %
Pricing & Reimbursement in Asia-Pacific	January 2006	£1095	8.75 %
Pharmaceutical Product Relaunch Preserving Market Share through Line Extension and New Market Entry Strategies	April 2007	£5080	8.75 %
Virbac Corporation - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
Inspire Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Pall Corporation - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
Manhattan Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Matrixx Initiatives, Inc. - Financial and Strategic Analysis Review	July 2009	£83	8.5 %
Qiagen N.V. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Nippon Kayaku Co., Ltd. - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
OPG Groep - Financial and Strategic Analysis Review	July 2009	£83	8.5 %
Nabi Biopharmaceuticals - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
UCB Group - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
Minrad International, Inc. - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
Jazz Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
DNA Sequencing: Emerging Technologies and Applications	January 2008	£3205	8.5 %
Boiron SA - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Chelsea Therapeutics International, Ltd. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Allergy Therapeutics plc - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
Anadys Pharmaceuticals, Inc - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Auxilium Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Averion International Corp. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Indevus Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
AVANIR Pharmaceuticals - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
eResearchTechnology, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Helix BioMedix, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Zila, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Schering-Plough Corporation - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
GTC Biotherapeutics, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Cyanotech Corporation - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
Endo Pharmaceuticals Holdings Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
King Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
3SBio Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Albany Molecular Research, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Alcon, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Australia Pharmaceuticals & Healthcare	February 2009	£250	8.5 %
Acusphere, Inc. - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals), The	October 2009	£2310	8.5 %
bioMerieux S.A. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Acrux Limited - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Alpha Innotech Corp. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Angiotech Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Biotech in Autoimmune and Inflammatory Disease 2006 2nd Edition	May 2006	£1980	8.5 %
Marketing Mid-Tier Pharmaceutical Brands Winning Resources for near-Blockbusters	May 2006	£2175	8.5 %
Evotec Aktiengesellschaft - Financial and Strategic Analysis Review	July 2009	£83	8.5 %
STERIS Corporation - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Allergan, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Favrille, Inc. - Financial and Strategic Analysis Review	April 2009	£83	8.5 %
Athersys, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8.5 %
Avexa Limited - Financial and Strategic Analysis Review	July 2009	£83	8.5 %
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments World Market	May 2007	£1320	8.4 %
The World Antibacterial Treatments Market 2010-2024	December 2009	£1499	8.4 %
Commercial Insight: Antidyslipidemics Branded statins beware, generics are amongst you	July 2006	£5575	8.4 %
Innovation in Drug Delivery The future of nanotechnology and non-invasive protein delivery	November 2006	£1495	8.4 %
Antiseptics and Disinfectants	February 2009	£3205	8.4 %
Clinical Trials Market 2006, The	February 2006	£1499	8.4 %
Epix Pharmaceuticals Inc Premium Company Profile	January 2008	£175	8.4 %
Biosimilars: a viable market?	September 2008	£1295	8.4 %
Johnson & Johnson to Acquire Mentor Corporation Expanding Presence in the Aesthetic Devices Market	December 2008	£330	8.4 %
Parallel Trade US Lawmakers Allow Imported Prescriptions Drugs	June 2007	£1499	8.4 %
Veterinary Health Markets	December 2008	£2245	8.4 %
Vaccines	March 2008	£600	8.4 %
Indian Biopharmaceuticals	January 2008	£600	8.4 %
Patient Compliance Europe	August 2006	£75	8.4 %
Commercial Insight: Cardiovascular market overview Raft of patent expires threaten blockbusters	October 2007	£5020	8.4 %
Injectable Drug Delivery: Market Impact and Industry Trends	October 2006	£1155	8.4 %
UK Healthcare IT Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1980	8.4 %
Alcon, Inc. Product Pipeline Analysis	August 2008	£495	8.4 %
Commercial Insight: Antidyslipidemics The competitive cost-conscious antidyslipidemics market presents challenges	July 2007	£5020	8.4 %
Indian Pharmaceuticals Industry Report	December 2009	£600	8.4 %
A Guide to Drug Pricing and Reimbursement	September 2007	£1580	8.4 %
Stakeholder Opinions: Back Pain Gain competitive edge by targeting subpopulations	March 2009	£1320	8.4 %
The Future of Metabolic Disorder Therapeutics Market Forecasts to 2015	December 2009	£2310	8.4 %
Pipeline Insight: Breast Cancer Recent approvals increase pressure on pipeline candidates	April 2008	£3965	8.4 %
The Pharmaceutical Industry 2008 Current and Future Trends and Strategic Issues Shaping Pharma	March 2008	£1980	8.4 %
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012	April 2007	£1499	8.4 %
Market for Bioengineered Protein Drugs; The	January 2007	£2885	8.4 %
Commercial Insight: Top 20 Cancer Therapy Brands Sales of targeted therapies overtake cytotoxics in 2006	July 2007	£5020	8.4 %
World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)	May 2009	£2310	8.4 %
The Future of Oncology Therapeutics Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis	December 2009	£2310	8.05 %
Biochips A Global Update of Market Trends & Opportunities	November 2009	£1980	8.05 %
The Outlook for Emerging Central American Pharmaceutical Markets 2009	January 2009	£795	8.05 %
Commercial and Pipeline Insight: Systemic antifungals	November 2007	£5020	8.05 %
Commercial and Pipeline Insight: ADHD Immature adult market continues to offer greatest commercial potential	April 2008	£5285	8.05 %
Forecast Insight: Multiple Sclerosis Tysabri to prevail despite safety setbacks	August 2008	£5020	8.05 %
Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries	July 2007	£5020	8.05 %
United States In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1980	8.05 %
Patient Empowerment Empowered Patients Can Change Healthcare Outcomes And Impact The Pharmaceutical Industry	July 2007	£1980	8.05 %
Commercial Insight Top 20 Cancer Therapeutics	July 2006	£5745	8.05 %
Molecular Diagnostics A World Market Review	November 2009	£1980	8.05 %
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family Sales & Marketing	October 2007	£2510	8.05 %
Cytology and HPV Testing World Markets	July 2008	£2245	8.05 %
Prostate Cancer Therapeutics A Global Market Perspective	November 2009	£1980	8.05 %
Stakeholder Opinions: Hormonal Contraceptives New directions in a competitive market	November 2006	£1325	8.05 %
Diabetes Drug Pipeline Competitor Analysis	November 2008	£1075	8.05 %
Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)	March 2003	£1320	8.05 %
Nanotechnology in Life Science Applications	October 2005	£2885	8.05 %
The Royalty Rate Report 2009 A Comprehensive Assessment of Valuation in the Pharmaceutical Sector	November 2008	£3594	8.05 %
Emotional and Behavioral Disorders in Children and Adolescents	September 2005	£2885	8.05 %
Leukemia - A Therapeutic & Competitive Insight	October 2006	£1745	8 %
Executive Summary of the BioChips & BioMEMS (Biomedical Microelectromechanical Systems) Markets 2006-2011 Analysis & Forecasts	May 2006	£725	8 %
Plant-Derived Drugs: Products, Technology, Applications	June 2006	£2885	8 %
etrials Worldwide, Inc. - Financial and Strategic Analysis Review	June 2009	£83	8 %
Overview of General Hospital Consumables and Cardiovascular Products Market in Sri Lanka	March 2009	£3965	8 %
Bioinformatics Report The forecasts and future of the market 2006-2011	October 2006	£1499	7.7 %
Pharmaceutical Pricing and Reimbursement Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies	February 2010	£2310	7.7 %
Competitor Analysis VEGF and VEGF-R Agonists and Antagonists	September 2009	£540	7.7 %
Diabetes, Metabolic Syndrome and Cardiovascular Disease Reshaping Tomorrow's Diabetes Market	April 2009	£2245	7.7 %
Cancer Therapeutics: The Worldwide Market The Worldwide Market , 2nd Editon	February 2007	£2640	7.7 %
Anti-Obesity Drugs Trends & Opportunities Worldwide	November 2009	£1980	7.7 %
Drug Delivery Systems US Market Outlook, Advances for Pharma, Biotech & Medical Devices	September 2006	£1515	7.7 %
The Global Antivirals Market R&D Pipelines, Market Analysis and Competitive Landscape	May 2007	£1650	7.7 %
Glaucoma Pharmaceuticals	February 2010	£2610	7.7 %
Therapeutic/Diagnostic Devices for Neurological Disorders	March 2007	£3205	7.7 %
Pharmaceutical Pricing And Reimbursement Strategies For Market Access Across The Us, Europe, Japan And Other Key Geographies	November 2007	£1495	7.7 %
Negotiating The Emerging Biosimilars Landscape Key Developments in The Regulatory Environment	February 2009	£2025	7.7 %
Stakeholder Insight: Osteoporosis Generic alendronate further establishes oral bisphosphonates as gold standard	October 2008	£5285	7.7 %
Sleep Disorders Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking	March 2009	£1320	7.7 %
Rx-to-OTC Strategies Maximizing The Commercial Potential of An Rx-to-OTC Switch	June 2008	£1980	7.7 %
Scrip R&D Databook 2006	January 2006	£1295	7.7 %
Pharmacy Automation: Technologies and Global Markets	January 2008	£3205	7.7 %
Commercial & Pipeline Insight: Hospital Antibacterials A market beyond MRSA	August 2007	£5290	7.7 %
Alcon, Inc. Medical Equipment Company Share Analysis	October 2008	£660	7.7 %
Canada Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012	May 2008	£1980	7.7 %
Genmab AS - Financial and Strategic Analysis Review	June 2009	£83	7.7 %
Generics in the Animal Health Industry	January 2006	£795	7.5 %
World market for cancer vaccines 2007-2012	January 2007	£1999	7.5 %
World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The	May 2009	£2640	7.5 %
Biosimilars: A Growing Market	March 2010	£1495	7.5 %
Prostate Cancer Drug Discoveries What The Future Holds	November 2009	£1295	7.5 %
Kinase Inhibitors: Global Markets	November 2009	£3205	7.5 %
Commercial Insight: Asthma & COPD	June 2009	£10040	7.35 %
Pipeline Insight: Colorectal Cancer Growing trend towards personalized medicine	October 2009	£7530	7.35 %
Cancer Diagnostic Testing World Markets	April 2008	£2245	7.35 %
Indian Medical Market Report 2005	May 2005	£735	7.35 %
Global Generics Guide: Part 2 Benchmarking country markets and strategic issue	June 2006	£5745	7.35 %
Commercial Insight: Antithrombotics Market expands as disease management focuses on prevention	October 2007	£5020	7.35 %
World Generics Market 2006-2011; The	May 2006	£1499	7.35 %
World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024	July 2009	£1499	7.35 %
Enzon Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	April 2009	£83	7.35 %
GenericHandbook - Third Edition (2009) A Guide to the Generic Drug Industry in the US	April 2009	£495	7.35 %
Injectable Generic Drugs Prospects & Opportunities to 2013	July 2008	£1295	7.35 %
Stakeholder Opinion: Atopic Dermatitis A high level of unmet need creates market opportunities	March 2007	£1325	7.35 %
Biotech Drug Delivery Systems Key Company Intelligence & Market Outlook to 2012	February 2007	£1299	7.35 %
BioSante Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£83	7.35 %
Global Protein Therapeutics Market, The Market Dynamics and Pipeline Analysis	December 2006	£1980	7 %
CNS Drug Discoveries What the Future Holds	November 2006	£1995	7 %
Wireless in Healthcare 2008 The Market for Bluetooth, Rfid, Zigbee, Uwb Wwan, Wman, WLAN and Other Technologies	May 2008	£2310	7 %
Anti-Obesity Treatments Analysis & Forecasts 2009-2024	February 2009	£1499	7 %
Global Diabetes Market; The Therapeutics, Diagnostics and Complications	August 2006	£1650	7 %
Commercial Insight: Pain Market Overview Non-Traditional Analgesics and Opioid Reformulations to Sustain Sector Growth	October 2008	£5285	7 %
Teva Generics Company Intelligence Report Company Intelligence Report	March 2009	£195	7 %
Bariatric (Obesity) Care Equipment & Surgical Devices Worldwide A Market Strategy Report	February 2006	£1320	7 %
Pipeline Insight: Acute Stroke Commercial Risk Offsets High Unmet Need	May 2008	£3965	7 %
Spain Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012	May 2008	£1980	7 %
Alzheimer's and Parkinson's Diseases A Global Update of Market Trends & Opportunities	November 2009	£1980	7 %
UK Drug Delivery Devices Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1980	7 %
Therapeutic Drug Market for Acne Sector Snapshot	May 2006	£330	7 %
Alzheimer's and Parkinson's Diseases A Global Update of Market Trends & Opportunities	November 2009	£1980	7 %
Bayer Healthcare Strategic Analysis Profile	February 2008	£520	7 %
Marketing to Life Scientists: Navigating Channels Through Segmentation Navigating Channels Through Segmentation	December 2005	£2970	7 %
Anti-Migraine Drugs	February 2010	£2610	7 %
The Global Drug Delivery Market Research Trends and Market Outlook	May 2006	£1320	7 %
Worldwide Contract Research Organization 2004 Vendor Analysis Assessment and Positioning	March 2005	£1945	7 %
CNS Generic Drugs: Prospects and Opportunities to 2012	April 2008	£995	7 %
Generic Competition, 2007–11 The impact of patent expiries on sales of major drugs	February 2007	£1375	7 %
Pricing & Reimbursement - Seven Major Markets Update	May 2008	£1980	7 %
All Change in the Advanced Wound Care Market 2009	May 2009	£795	7 %
Allergy Drugs	February 2010	£2610	7 %
Global Pharmaceuticals, Biotechnology & Life Sciences	May 2008	£150	7 %
Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth	October 2008	£5285	6.65 %
Global Medical Markets for Nanoscale Materials and Devices	January 2008	£3205	6.65 %
In Vitro Diagnostics Market Report & Analysis 2008-2023	June 2008	£1499	6.65 %
Anti-Aging Products to 2009	June 2005	£2775	6.65 %
Global Image Dermatology Drug Market, 2005-2012, The High-Growth Opportunities in Aesthetic Medicine	November 2005	£795	6.65 %
Drug Discovery Technologies A Global Update of Market Trends & Opportunities	November 2009	£1980	6.65 %
Bio-Device Licensing: Strategies for Success	January 2006	£1095	6.65 %
World Market for Biosimilars and the Potential for US Follow-on Biologics, The	August 2009	£2445	6.65 %
Global Generics Industry Report	September 2006	£550	6.65 %
Launch Strategies - Analyzing Market Trends and Regulatory Impacts	August 2007	£5290	6.65 %
Weight Control Products and Services to 2008	February 2005	£2575	6.65 %
Probiotics A Global Update of Market Trends & Opportunities	November 2009	£1980	6.65 %
Cosmeceuticals US industry forecasts for 2012 & 2017	October 2008	£3105	6.65 %
Nissan Chemical Industries, Ltd. - Financial and Strategic Analysis Review	June 2009	£83	6.65 %
Pipeline Insight: Orphan Diseases in Neurology Part III: Myasthenia Gravis	November 2008	£3965	6.65 %
U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products	March 2006	£1980	6.65 %
Ophthalmological Therapeutics Pipelines, Delivery Technologies, and Markets	January 2008	£745	6.65 %
Pipeline Insight: Benign Prostatic Hyperplasia - Novel therapeutics and reformulations will drive market growth	April 2009	£3965	6.65 %
Biomarker Technology Platforms for Cancer Diagnoses and Therapies	April 2008	£2245	6.65 %
Biosimilars and Follow-On Biologics Report The Global Outlook 2009-2024	April 2009	£1499	6.5 %
Global Protein Therapeutics Market Analysis	August 2009	£1190	6.3 %
Gastrointestinal Disorders Market Intelligence to 2012	May 2007	£1499	6.3 %
Global Biotech Market Analysis and Forecasts, 2008-2023	August 2008	£1499	6.3 %
Biomanufacturing Strategies Market Drivers, Build-Vs-Buy Decisions And Opportunities In Contract Relationship Management	September 2007	£1495	6.3 %
Global Market for Antimicrobials and Antifungals; The Challenging Resistance to 2016	December 2006	£1600	6.3 %
Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value	October 2008	£5285	6.3 %
Autoimmune Disease Therapeutics	July 2009	£2610	6.3 %
Competitive Outlook on HCV What to Know & Expect in R&D and Business Development	June 2004	£895	6.3 %
Wireless Opportunities in Healthcare The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies	January 2007	£2640	6.3 %
United Kingdom Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012	May 2008	£1980	6.3 %
Clinical Laboratory Testing Volume 2: Business Strategies	April 2009	£1320	6.3 %
Sterilization Technologies: The U.S. Market	November 2009	£3205	6.3 %
Fastest Growing Biotechnology Companies, The Growth Strategies, Comparative Analyses and Company Profiles	March 2008	£1995	6.3 %
Enzymes US industry forecasts to 2010 & 2015	July 2006	£2840	6.3 %
Rx to OTC Switches 2009	April 2004	£2640	6.3 %
European Hospital Purchasing Practices Sector Snapshot	April 2006	£330	6.3 %
Biosimilars: Benchmarking the key players With increasing regulatory clarity and high revenue potential, interest in biosimilars increases	December 2006	£2640	6.3 %
Evolving Trends in Biopharmaceutical Licensing Deal assessments, drivers and resistors	March 2009	£2025	6.3 %
China Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012	May 2008	£1980	6.3 %
Indian Biopharmaceuticals Industry Report	January 2007	£400	6.3 %
Substance Dependence - Part II: Alcohol Pipeline Insight	December 2007	£2510	6.3 %
Bigpharma Agreements Handbook Partnering Agreements	September 2008	£1195	6 %
Bigpharma Partnering Agreements	March 2008	£1195	6 %
McKesson Corporation Healthcare - Medical Equipment SWOT Report	August 2008	£83	5.95 %
Organ Transplant Immunosuppressive Markets	January 2008	£2310	5.95 %
Pipeline Insight: Neuropathic Pain Emerging Drugs Fail To Capitalize In Lucrative Market	September 2007	£395	5.95 %
Point of Care Diagnostic Testing World Markets	September 2008	£2245	5.95 %
Drug Delivery Technology: Revolutionizing Diabetes Treatment	September 2007	£945	5.95 %
United States Nephrology & Urology Devices Medical Equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Renal Dialysis Equipment, Lithotripters and Incontinence Medical Devices and Supplies	April 2008	£1980	5.95 %
Complete Guide to the 2009 PPRS, NICE and other Pharmaceutical Cost Containment Measures in the United Kingdom	April 2009	£850	5.95 %
Covidien Ltd.Tyco Healthcare Medical Equipment Company Share Analysis	September 2008	£660	5.95 %
Companion Biomarkers in Drug Development	April 2009	£2245	5.95 %
Bioinformatics Markets Strategies, Business Models and Trends for the Future	March 2009	£2245	5.95 %
Blood Banking and Blood Products Global Market Perspective	November 2009	£1980	5.95 %
Infectious Diseases Drugs Markets	October 2009	£2245

Search Results

Results for 'Pharmaceutical Sales Management'